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ABSTRACT OF THE DISSERTATION
The Effects of Mild Concussions and Pomegranates on Behavior
by
Nikita M. Bajwa
Doctor of Philosophy, Graduate Program in Experimental Psychology
Loma Linda University, June 2016
Dr. Richard E. Hartman, Chairperson

The neuropathological effects of mild concussions can accumulate, leading to the
development of motor and cognitive deficits. Although there are currently no treatments
that can restore lost function after repetitive concussion, our laboratory has shown that
dietary supplementation with pomegranate polyphenols can improve Alzheimer’s-like
pathology, protect mice from the effects of proton irradiation, and protect humans from
post-operative cognitive deficits. This study investigated the behavioral and
neuropathological effects of repetitive concussions in mice and the use of dietary
supplementation with pomegranate to ameliorate these effects. Adult mice were given
dilute pomegranate juice or control water for 1 week, followed by anesthesia, repeated
anesthesia (3 days apart), or repeated concussive injury (a single closed-head injury to
each hemisphere 3 days apart). They were then maintained on the pomegranate juice or
control water for 2 additional weeks. Behavioral testing was administered 1, 3, 5, and 711 days post injury to assess cognitive, motor, and affective functions. Repeated
concussion, but not repeated anesthesia, induced motor and learning deficits, some of
which were significantly reduced by pomegranate juice. These data suggest that the
model of mild repeated concussive injury in mice might be used to test neuroprotective
treatment in future studies.

xii

CHAPTER ONE
INTRODUCTION

Traumatic brain injury (TBI) can be caused by external force to the head or body.
TBIs present a serious and emerging medical problem and are the leading cause of death
and disability in combat and civilian circumstances, with an estimated 1.7 million people
affected annually (H. Yu, Watt, & Mohan, 2014). Falls are the leading cause of TBI in
the United States (U.S.) (Faul, Likang, Wald, & Coronado, 2010), and other causes
include motor vehicle accidents, sports injuries, and violence (H. Yu et al., 2014).
Survivors may experience ongoing and permanent changes to brain structures, leading to
long-term cognitive, motor, and personality changes that ultimately increase the risk of
developing future neurological disorders. The U.S. military has recently reported that an
estimated 22% of all combat wounds in recent military conflicts were brain injuries, and
that TBIs are now referred to as the “signature wound” (H. Yu et al., 2014). This
phenomenon affects all ages and socioeconomic classes, with millions being hospitalized
for one or more TBIs. In addition, TBI also has a large economic impact with annual
costs in the U.S. totaling an estimated $60 billion and continuing to rise each year
(Langlois, Rutland-Brown, & Wald, 2006). TBI is a major public concern, and despite
the high incidence of TBI, few preventative and treatment options are available
(Chauhan, Gatto, & Chauhan, 2010).
TBI may be classified based on severity (e.g. mild, moderate, or severe), injury
location, time of lost consciousness (H. Yu et al., 2014), and clinical imaging techniques
such as magnetic resonance imaging (MRI) are used to classify injuries. Impact injuries
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produce damage when the head makes contact with an object, and penetrating injuries
occur when an object passes through the protective covering of the skull resulting in
direct parenchymal damage (Smith, 2013). Injuries can range from mild concussions,
with symptoms lasting from seconds, to more severe injuries with symptoms lasting years
or even causing death. The recoveries of motor and cognitive functions are dependent on
the severity of injury, with larger injuries corresponding to longer recovery time (Huh,
Widing, & Raghupathi, 2011).
The principal mechanisms of TBI are classified as either focal brain damage
caused by a contact injury resulting in contusion, laceration, and intracranial hemorrhage,
or diffuse brain damage caused by acceleration and/or deceleration, resulting in diffuse
axonal injury or swelling (Werner & Engelhard, 2007). The outcome from head injury is
determined by two substantially different stages: primary and secondary injury. Primary
injury occurs immediately at the moment of trauma and results in the displacement of the
structures in the brain. These injuries include damage to vasculature and cortical tissue
that may be diffuse or focal in nature. Secondary injuries occur following the primary
injury, in which the consecutive pathological processes initiated at the moment of injury
remain heightened over time and lead to delayed clinical presentation of symptoms.
These include the activation of inflammatory responses associated with brain swelling
that may cause further injury to regions that were not initially impacted.
Mild TBI (mTBI) accounts for 75% of all TBIs in the U.S. each year (Gerberding
& Binder, 2003) and may result in cognitive, motor, and emotional deficits that lead to
social problems, disability and/or unemployment (Baratz et al., 2011; Bazarian et al.,
2005). The risk of experiencing more severe brain injuries and long lasting behavioral
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deficits increase with each repeated mild TBI (rmTBI). Individuals who have experienced
one brain injury are three times more likely to experience a second brain injury
(Gerberding & Binder, 2003).

Behavioral Impairments after TBI
Mild (concussion; brief loss of consciousness) to moderate TBI (1 – 24 hours of
loss of consciousness) leads to impairment in executive processing, long-term memory
consolidation (Miotto et al., 2010), strategy and decision-making (Miotto et al., 2010; van
Noordt & Good, 2011), episodic memory, and verbal recognition and verbal episodic
memory tasks (Miotto et al., 2010). Deficits from mild TBI typically resolve within a
short amount of time, whereas moderate TBI recovery may take several weeks to months
(Ajao et al., 2012). Severe TBI (> 24 hours of loss of consciousness) leads to significant
cognitive and motor deficits, long lasting behavioral impairments and permanent
functional damage as a result of extensive tissue degeneration.
Closed head concussive injuries (CHIs) have been gaining significant attention
within the research community. Typically, people with CHIs experience a variety of
symptoms, including headache, dizziness, nausea, confusion, abnormal balance, cognitive
impairments, and sleep disruption (Slobounov, Gay, Johnson, & Zhang, 2012).
Conventional wisdom has been that typical recovery following a concussion is rapid and
full, with no residual physical or cognitive impairments. However, there is growing
evidence that suggests CHIs may be far more detrimental than previously thought, with
cognitive, affective, and underlying neural changes persisting for months or even years
post-injury (Slobounov et al., 2012), including an increased risk for neurodegenerative
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diseases such as Alzheimer’s disease and chronic traumatic encephalopathy (Petraglia et
al., 2014).
Concussive-type of injuries are rotational and more diffuse in nature,
characterized by extensive lesions in the white matter tracts in the brain, and lead to
widespread damage that occurs with increasing severity (Adams et al., 2011). The
disruption in neuronal communication throughout the brain may lead to subsequent tissue
damage and behavioral deficits (Kinnunen et al., 2011). In a recent study published by
our lab, we used a mild closed head injury (mCHI) model to characterize long-term
behavioral deficits in young adult mice with a single mCHI and repeated mild CHI
(rmCHI). We found that this model produced consistent mild rotational injuries that led
to the emergence of late-appearing (90 days post-injury) motor and affective deficits
(Bajwa, et al., 2016).
Because the risk of experiencing more severe brain injuries and the resulting
behavioral deficits increases with each rmTBI, collaborators have recently used a mild
TBI model to better investigate the temporal development of neuropathology using MRI
to assess the effects of rmTBI by administering 1 impact to each cortical hemisphere
(Donovan et al., 2012). They found tissue damage to be exacerbated following the second
mTBI, especially when the injuries were seven days apart. These studies were also
extended to investigate white matter and found abnormalities as late as 60 days post
injury (dpi) (Donovan et al., 2014). Similarly, our group has shown that brain injury early
in life induced long-term white matter abnormalities, delayed development, and persistent
behavioral deficits (Ajao et al., 2012). Mice that were exposed to 3 concussive injuries 24
hours apart experienced prolonged loss of consciousness and impaired spatial learning in
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behavioral tasks (Creeley, Wozniak, Bayly, Onley, & Lewis, 2004). Another rmTBI
model, in which repeated impact to the cranium was delivered to an unrestrained mouse,
induced hyperactivity and motor coordination deficits (Kane et al., 2012). An rmTBI
model in which rats were given 1, 3, or 5 mild injuries spaced five days apart induced
short (24 hr) and long-term (8 weeks) cognitive impairments (Shultz et al., 2012). These
studies suggest that the brain remains vulnerable to a subsequent injury for a period of
time after injury, increasing the probability of behavioral deficits.

Rodent Models of TBI
The pathophysiological heterogeneity observed in patients with TBI may arise
from the nature and severity of the primary injury and any preexisting combination of
factors that include, but are not restricted to, age, overall health, gender, medication, and
genetics (Margulies & Hicks, 2009). Animal models of TBI are intended to produce a
relatively homogenous type of injury, with age, gender, medication, and genetic
background and all injury parameters controlled (Xiong, Mahmood, & Chopp, 2014).
These models are also essential to study the biochemical, cellular and molecular aspects
of human TBI that cannot be assessed in a clinical setting, in addition to developing and
characterizing therapeutic interventions (Xiong et al., 2014). Experimental models of TBI
are categorized as open- or closed-head, depending on whether the skull is broken or not
(Obenaus et al., 2012). The degree of injury can be easily manipulated by various
parameters, and more severe injuries generally induce larger locomotor and cognitive
deficits (Brody et al., 2007; Obenaus et al., 2012).
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Controlled Cortical Impact
The controlled cortical impact (CCI) model allows for independent control of
many mechanical parameters and produces many features found in human TBI (Obenaus
et al., 2012; S. Yu et al., 2009). This model uses a pneumatic or electromagnetic impact
device to drive a motorized piston through a unilateral craniectomy onto the exposed
intact dura, and produces cortical tissue loss, acute subdural hematoma, axonal injury,
concussion, and blood brain barrier dysfunction (Brody et al., 2007; Chauhan et al., 2010;
V. Donovan et al., 2012; Virginia Donovan et al., 2014; Huang et al., 2013; Obenaus et
al., 2007; D. H. Smith et al., 1995).
The controlled impact breaks the dura and results in the deformation of the
underlying cortex. Although this model delivers a focal injury, further evaluation has
revealed that the damage can include other distant areas including the acute cortical
region, hippocampus, and thalamus (Hall et al., 2005). Behavioral deficits are evident in
motor tasks and learning and memory (Ajao et al., 2012; Brody et al., 2007; Scheff,
Baldwin, Brown, & Kraemer, 1997; S. Yu et al., 2009). The advantage of the CCI model
compared to others is that TBI severity can be manipulated by varying the piston’s speed
and/or depth, producing consistent injuries for mild (including concussion), moderate,
and severe TBI. Larger depth and speed induce more locomotor and cognitive deficits
(Brody et al., 2007).

Fluid Percussion Injury
The fluid percussion injury (FPI) model is one of most widely used TBI animal
models that produces features found in human TBI. In this model, the injury is inflicted
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by a pendulum striking a water-filled acrylic cylinder with high-pressure tubing that is
connected to the injury hub glued to the craniectomy site (along the midline or laterally
over the parietal bone; McIntosh et al., 1989) on the mouse. A fluid pressure pulse is
delivered to the intact dura and generates a combination of focal and diffuse tissue injury
that can cause intracranial hemorrhage, brain swelling, and progressive axonal damage
(Graham, McIntosh, Maxwell, & Nicoll, 2000). This model is commonly used, because it
produces cognitive and motor deficits (Shultz et al., 2012) that are seen in patients with
TBI.
However, there are several limitations in the FPI models. Mortality is very high
compared with other models because it is invasive, requires longer surgery, and there is
minimal biochemical control of the insult, with only one adjustable mechanical
parameter. Thus, injury reproducibility is a large problem in this model. Adjustments to
the model have been made to the delivery mechanism and shorter surgical duration, but
limited to rats only (Kabadi, Hilton, Stoica, Zapple, & Faden, 2013).

Weight Drop
The weight drop model is an impact acceleration model that uses a free falling,
guided weight to fall onto the exposed rodent skull (with or without craniotomy) to
produce motor and behavioral deficits seen in TBI (Creeley et al., 2004; Kane et al.,
2012; Kilbourne et al., 2009; Marmarou et al., 1994). This model was developed by
Marmarou et al. (1994) to produce diffuse axonal injury to mimic human TBI by falls or
motor vehicle accidents. This simple model produced a graded, rotational injury in
rodents without extensive changes in blood pressure or brain stem damage, and injury
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severity can be simply altered with the adjustment of weight and height from where the
object is released (Marmarou et al., 1994).
One of the disadvantages of this model is the high variability in injury severity
and skull fractures. This presents a critical problem in consistency among results and
reproducibility difficulties. In a recent modification of this model (the “Maryland
model”), the impact force is applied to the anterior part of the cranium and produces a
rotational TBI inside the intact cranium (Kilbourne et al., 2009). Injury features are
characterized by an absence of cortical contusions, skull fractures, prolonged apnea, and
an absence of mortality, but demonstrate mild subcutaneous hemorrhages and diffuse
axonal injury (DAI) (Kilbourne et al., 2009). This model will need to be studied further
for consistency and characterization.

Blast Waves
Many military personnel exposed to shock waves from a blast (explosive device)
without any penetrating external injuries have been diagnosed with TBI (Benzinger,
Brody, Cardin, Curley, & Mintun, 2009; Warden, 2006). Blast injuries cause diffuse
tissue injury that lead to chronic neuroinflammation (Goldstein et al., 2013), axonal tissue
damage (Garman et al., 2011), learning and memory deficits (Budde et al., 2013), and
other motor and behavior abnormalities (Budde et al., 2013; Goldstein et al., 2013). To
recreate the effects of primary blast waves on the central nervous system, several animal
models of blast TBI have been established, mainly in rodents (Cernak et al., 1996; Cheng
et al., 2010; Long et al., 2009; Risling & Davidsson, 2012; Y. Wang et al., 2011) and
swine (Bauman et al., 2009; Lanerolle et al., 2011) that use a compression-driven shock
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tube to induce an indirect TBI.
One of the disadvantages of these models is the high variability in injury severity
and skull fractures (Xiong et al., 2014). This presents a critical problem in the
reproducibility of the studies and further standardization of methods needs to be
established.

Closed Head Injury (CHI)
CHI is a rodent model of TBI that is more representative of mTBI/concussive
conditions than the more invasive CCI and FPI models that require craniectomy, which
may itself lead to cortical inflammation and behavioral changes (Mouzon et al., 2012). In
the CHI model, the pneumatic or electromagnetic impact device drives a motorized
piston to impact the skull directly. This model produces a mild injury that prevents
cortical contusions, skull fractures, prolonged apnea, and also keeps mortality to a
minimum (Mouzon et al., 2012). The skull and dura remain intact, and the brain rotates
inside the skull, causing more diffuse cortical damage that leads to significant motor and
behavioral deficits. We have recently characterized a mild CHI (mCHI) and repeated
mild CHI (rmCHI) model that produced long-term behavioral and affective deficits
(Bajwa et al., 2016). Mice were placed on a foam base to allow for head rotation after
impact with a motorized piston. MRI at 90 days did not reveal cortical depression and
confirmed the mild feature of our model. We believe the rotational nature of this model
resulted in widespread tissue damage that lead to the emergence of deficits.
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Biological Responses after TBI
The pathophysiology of TBI is complex and multifactorial, with several pathways
involved in the damage of the brain tissue. Primary injury occurs from a direct external
mechanism force at the moment of trauma that leads to skull fractures, brain contusions,
lacerations, diffuse axonal injuries, vascular tearing, and intracranial hemorrhages. This
impact directly damages neural tissue and causes drastic chemical changes (e.g.
excitotoxicity, increased Ca2+) in the brain (Povlishock & Christman, 1995). Secondary
injury is induced immediately after primary injury and is mediated by several
mechanisms, including raised intracranial pressure, disruption of the blood brain barrier,
brain edema, decreased cerebral blood flow, cerebral hypoxia, and ischemia (Graham et
al., 2000). The blood brain barrier is compromised after TBI, which triggers a potent
inflammatory response with a cascade of molecular, neurochemical, and cellular
responses such as such as excitotoxicity (over activation of neurotransmitters),
disturbance of cellular homeostasis, oxidative stress, cytoskeletal and mitochondrial
dysfunction, inflammation, and apoptosis (cell death) (Povlishock & Christman, 1995).
This secondary response dramatically increases the neuronal damage from the primary
injury, inducing white matter abnormalities (Virginia Donovan et al., 2014; Huang et al.,
2013) and behavioral deficits (Ajao et al., 2012; Brody et al., 2007; Hartman, 2012;
Kamper et al., 2013; Lekic et al., 2011).

Neuroinflammation after TBI
Activation of the immune system in the central nervous system has become
increasingly recognized as a key component of the normal process of aging, but also the
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pathological onset and progression of many neurological disorders, including TBI and
neurodegenerative diseases. The initial inflammatory response after TBI results in
neuronal injury and the permeation of the blood-brain barrier (Smith et al., 1997) and the
activation of several injury cascades. This impact to the central nervous system results in
several factors (blood products, tissue debris, prostaglandins, reactive oxygen and
nitrogen species; Dardiotis et al., 2012) triggering the secondary injury response with the
activation of resident cells (e.g., microglia and astrocytes), migration and recruitment of
leukocytes (white blood cells), and the release of inflammatory mediators.

Microglia
Once the immune response is initiated, microglial cells become activated within
minutes and take on a predominantly pro-inflammatory role. They release proinflammatory chemokines and also produce other neurotoxic products after injury such as
nitric oxide and superoxide free radicals that generate reactive oxygen species and
reactive nitrogen species. The initial pro-inflammatory response is to promote the
termination of invading pathogens, remove dead cells, and clean the surrounding area.
Thereafter, the response is shifted to an anti-inflammatory state, in which debris
clearance, extracellular matrix deposition, and new capillary blood vessel growth are
promoted (Cherry et al., 2014). TBI can further exacerbate microglial activation and
promote long-term tissue damage and subsequent behavioral impairments. In a midline
fluid percussion injury model, the diffuse injury leads to the sensitization of microglia
and the inflammatory system, which contributed to the depressive-like behavior found in
the tail suspension test at 72 hours post TBI dpi (Fenn et al., 2013). Microglia also
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remained primed and reactive up to 30 dpi, as a result of the prolonged secondary injury
response (Fenn et al., 2013). In several other animal models of brain injury, microglia
also remain activated for at least 1 year (Jacobowitz, Cole, McDaniel, Pollard, & Watson,
2012; Jin, Ishii, Bai, Itokazu, & Yamashita, 2012; Nagamoto-Combs, McNeal, Morecraft,
& Combs, 2007; D. H. Smith et al., 1997). In humans, long-term inflammation is
considered to be a contributing factor to sustained damage following brain injury, with
activated microglia and white matter degeneration persisting for years after a single TBI
in humans (Johnson et al., 2013), as well as up to 17 years after TBI in the subcortical
regions (thalami and putamen) distant from the site of injury (Ramlackhansingh et al.,
2011). These studies suggest that the detrimental effect of chronic inflammation
following TBI is mediated by microglia in the brain.

Protective Effects of Antioxidants in Brain Injury Induced Deficits
Since each patient with brain injury has a unique and complex pattern of tissue
damage, developing pharmacological intervention strategies that target the multiple
cellular and molecular events in the neuroinflammatory cascade is difficult. Injury results
in increased oxidative stress, cellular dysfunction, and other factors may ultimately result
in neuronal death. Despite advances in prevention measures, surgical, and diagnostic
techniques, there have been few successful outcomes in human clinical trials of drugs
developed to treat TBI. There have been few changes in the way TBI patients are
managed, and most drugs and techniques have aimed to reduce brain pressure and
swelling. So far, there is no pharmacological treatment currently available for clinical use
that specifically targets secondary brain injury mechanisms to improve outcome
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(Woodcock & Morganti-Kossmann, 2013). There are several different types of
antioxidant/anti-inflammatory items found, including those in drugs, natural compounds
(e.g., vitamins), and those that are found in fruits and vegetables (i.e., phytochemicals).
Some have been found to be more effective in reducing brain injury induced deficits, and
these effects are reviewed in the next sections.

Antioxidant Drugs
There are few pharmacological interventions available for TBI and these include
the administration of psychostimulants, antidepressants, antiparkisonian drugs, and
anticonvulsants (Talsky et al., 2011). Unfortunately, these are only implemented after the
injury has occurred to control adverse symptoms, which may be too late to prevent
significant neurodegeneration in the brain. Antioxidant therapies have been directed
towards the inhibition of the secondary injury cascade in acute TBI by the
pharmacological targeting of a single oxidative damage mechanism. Several experimental
models of brain injury in rats have found N-Acetylcysteine to attenuate glutamate related
excitotoxicity and reduce infarct size (Krzyzanowska, Pomierny, Budziszewska, Filip, &
Pera, 2016), decrease apoptosis and neuronal degradation in the tissue surrounding the
lesion (Gunther et al., 2015), and decrease oxidative stress and apoptosis in the
hippocampus (Naziroglu, Senol, Ghazizadeh, & Yuruker, 2014). Treatment with
deferoxamine has also attenuated neuroinflammation (Zhang, Cao, Zhang, Li, & Mi,
2015), cognitive deficits (Zhang et al., 2013; Zhang et al., 2015), and reduced white
matter degeneration (Xie et al., 2014) in several experimental animal models. Though
several types of anti-oxidant compounds have been tested in animal models, few have
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found success in clinical trials. Polyethylene glycol-conjugated superoxide dismutase
(PED-SOD) was found to act as a scavenger of free radicals and this prevented posttraumatic microvascular dysfunction (Muizelaar et al., 1993). However, when PEG-SOD
was administered in moderate and severe TBI patients within the first 8 hours of injury,
results failed to show consistency or improved survival and neurological outcomes in the
phase 3 clinical trial (data not published; discussed in Muizelaar et al., 1993), despite
short lived success in the phase 2 clinical trial (Muizelaar et al., 1993). Another drug
called Tirilazad (21-aminosteroid lipid peroxidation inhibitor) inhibited free radical lipid
damage and stabilized membranes and has been found to lessen post-traumatic blood
barrier opening in diffuse concussive head injury models (Hall, Yonkers, Andrus, Cox, &
Anderson, 1992). However, when taken in clinical trials within 8 hours of injury, the drug
failed to show a beneficial effect after either moderate or severe TBI (Marshall et al.,
1998).

Naturally Occurring Antioxidants
Many studies suggest that diets high in antioxidant properties may reduce
oxidative damage and attenuate neuronal degradation via multiple pathways. Vitamin E
(-tocophernol and -tocotrienol) and vitamin C (L-ascorbic acid or L-ascorbate) are
naturally occurring antioxidants that have shown to counteract the effects of TBI. Rats
pretreated with vitamin E before mild FPI injury had lower levels of oxidative stress that
improved synaptic plasticity (communication between neurons) and learning performance
when tested in the water maze (Wu, Ying, & Gomez-Pinilla, 2010). Similarly, vitamin E
administered before brain injury reduced oxidative stress levels in a mouse model of
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Alzheimer’s disease (Conte et al., 2004) and guinea pigs (Inci et al., 1998). Despite the
results from animal research, no clinical studies have been conducted to test the effect of
vitamin E in TBI and other clinical studies with various other forms of brain trauma (e.g.
stroke) have generated mixed results. Neither animal nor clinical studies have examined
the potential neuroprotective effects of vitamin C on TBI, and clinical studies with other
mechanisms of brain trauma (e.g. stroke) did not find a neuroprotective effect.

Phytochemicals
Phytochemicals are chemical compounds that occur naturally in plants and their
antioxidant properties may have neuroprotective and anti-degenerative functions by
reducing cellular apoptosis and slowing the progression of neuronal cell loss. Studies
have shown that phytochemicals reduce oxidative stress by the activation of the Nrf2
transcription factor (regulates expression of antioxidant proteins) and scavenging free
radicals. Sulforaphane, an organosulfur compound that is found in cruciferous vegetables
(e.g broccoli), decreased edema following TBI in rats (Zhao, Moore, Redell, & Dash,
2007) and up-regulated neuroprotective genes (Nrf2 driven genes), maintained blood
brain barrier integrity (Zhao, Moore, Clifton, & Dash, 2005), and improved performance
in the water maze (Dash, Zhao, Orsi, Zhang, & Moore, 2009).
The antioxidant compounds in green tea (catechins and epicatechins) protected
neurons against mitochondrial dysfunction (Chen, Lin, Liu, & Lin-Shiau, 2008),
prevented neuronal damage in the hippocampus (Park et al., 2009), and reduced both glial
swelling (Panickar, Polansky, & Anderson, 2009) and oxidative damage (Etus, Altug,
Belce, & Ceylan, 2003).
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Polyphenols
Polyphenols are water soluble, organic chemicals found in spices and fruits have
antioxidant and anti-inflammatory properties. Supplementing polyphenols into diets may
be more effective in the treatment of neuroinflammation, injury related deficits, and
slowing progression neurological diseases as compared to pharmaceutical medications.
Curcumin (a polyphenol found in the spice turmeric) reduced oxidative protein levels and
improved synaptic plasticity and cognition (learning and memory tasks) in rats with mild
TBI (Wu, Ying, & Gomez-Pinilla, 2006). Similarly, treatment with curcumin after mild
TBI also protected against injury-induced fine motor deficits and hippocampal synaptic
dysfunction (Wu, Zhing, Schubert, & Gomez-Pinilla, 2011). Curcumin administration
after CHI also reduced acute activation of microglia and other inflammatory processes in
mice (Zhu et al., 2014). Similar findings were observed in a model of intracerebral
hemorrhage (Yang, Zhao, Zou, Zhang, & Feng, 2014).

Fruit Polyphenols
Fruits contain powerful antioxidant and anti-inflammatory properties that provide
neuroprotection against oxidative damage in the brain (Ates et al., 2007). The antioxidant
polyphenols found in fruits have been shown to lessen age related deficits in rodents
(Joseph et al., 1998; Shukitt-hale, Carey, Jenkins, Rabin, & Joseph, 2007; Shukitt-Hale,
Carey, Simon, Mark, & Joseph, 2006; Shukitt-Hale, Cheng, & Joseph, 2009). These have
also been shown to attenuate several age-related diseases including Alzheimer’s disease
(Hartman et al., 2006; Joseph et al., 2003). Therefore, these dietary antioxidant and anti-
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inflammatory compounds may protect against TBI-induced inflammation and associated
behavioral deficits, and ultimately improve prognosis.
The polyphenols found in fruits have been shown to protect against
neuroinflammation (Dulcich & Hartman, 2013; Hartman et al., 2006; Milardi, Stringaro,
Colone, Bonincontro, & Risuleo, 2014; Shukitt-Hale et al., 2008; West, Atzeva, &
Holtzman, 2007) by increasing the antioxidant and free-radical scavenging properties
(Priyadarsini, Khopde, Kumar, & Mohan, 2002; Singleton et al., 2010), though the exact
mechanisms of neuroprotective activities remain unclear. Blueberries have been shown to
decrease cortical microglial activation (Lau, Bielinski, & Joseph, 2007; Y. Zhu, Bickford,
Sanberg, Giunta, & Tan, 2008) and oxidative stress (Goyarzu et al., 2004; Shukitt-Hale et
al., 2008). Data from our lab suggests that AD transgenic mice pretreated with a grapeenriched diet significantly reduced lesion volume after mild TBI (preparing submission).
Resveratrol (a polyphenol found in grape skin) has also been shown to decrease
hippocampal oxidative damage (de Almeida et al., 2008; Singleton, Yan, Fellows-Mayle,
& Dixon, 2010) and cortical microglial activation (Gatson et al., 2013). Resveratrol
injected in 7-day-old rat pups immediately after blunt head trauma increased exploratory
activity to that of controls 14 days after injury, whereas injured pups without treatment
had lower activity levels and increased anxiety behaviors (Sönmez, Sönmez, Erbil,
Tekmen, & Baykara, 2007). Resveratrol injected in adult rats as 3 post-injury doses
protected against contusion volume and hippocampal neuronal loss (Singleton et al.,
2010). Supplementation post-TBI may alone dramatically increase individual motor and
cognitive prognosis.
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Pomegranate Polyphenols
Pomegranate is an important source of bioactive compounds, and different parts
of it have been used in traditional medicine for many centuries. The healing properties of
pomegranates can be attributed to the fruit’s high polyphenol content and have been
associated with its antioxidant and anti-inflammatory properties (Dorsey & Greenspan,
2014; Ismail, Sestili, & Akhtar, 2012; Seeram et al., 2005; Vegara et al., 2014). All parts
of the fruit contain polyphenols, including the peal, the inner membranes, and the arils;
although the peel and membrane are reported to contain the highest concentrations (Gil et
al., 2000). Pomegranate juice contains 2 major classes of polyphenolic compounds:
hydrolyzable tannins (break down in water) and flavonoids. The hydrolyzable tannins are
the most abundant polyphenols in the juice and include ellagitannins, gallotannins, and
gallagoyl esters (Gil et al., 2000). The flavonoids consist of anthocyanidins (pigments
that color the juice), flavanols, and flavanol glucosides (Gil et al., 2000). The activity of
the polyphenolic components of pomegranate juice have been reported to decrease
oxidative stress and act as scavengers for free radicals (Priyadarsini et al., 2002). Ellagic
acid alone has demonstrated its ability to reduce free radicals, oxidative stress, reactive
nitrogen species (Priyadarsini et al., 2002), and protein modification (Dorsey & Greenspan,
2014). Pretreatment of ellagic acid (daily doses 7 days prior to TBI induction)

significantly reduced hippocampal mediated memory impairments and inflammatory
markers (IL-1 and IL-6 cytokines) in rats (Farbood et al., 2015). Clinical studies have
reported pomegranate juice to have anticancer (Pantuck et al., 2006) and cardiovascular
effects (Aviram et al., 2004; Aviram & Dornfield, 2001; Rosenblat et al., 2006; Sumner
et al., 2005).
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Neuroinflammation and behavioral deficits resulting from TBI are similar to those
seen in Alzheimer’s disease. Anti-inflammatory polyphenols found in pomegranate juice
(0.2-1.0% polyphenols; PomWonderful) have been found to attenuate Alzheimer’s-like
pathology in mice (Hartman et al., 2006). In this study, Hartman et al. used a 1:20 diluted
concentration of pomegranate juice and found significant improvements in behavior and
neuropathology. This dilution was roughly equivalent to two 8-ounce glasses of juice per
day for humans. Mice that consumed the pomegranate-enriched water for 6 months
improved in spatial learning tasks (the water maze) and had significantly reduced
hippocampal amyloid beta plaques. In another study, maternal supplementation with
pomegranate juice influenced mice pup outcome after brain injury (Loren, Seeram,
Schulman, & Holtzman, 2005). Mouse pups subjected to neonatal stroke had less cortical
tissue loss than controls when exposed in utero to pomegranate juice, regardless of dose.
Also, pomegranate juice supplementation (1:20 dilution) for 10 weeks ameliorated
irrdiation (2 Gy) induced depression-like behavior and improved motor performance in
male mice (Dulcich & Hartman, 2013) and increased neurogenesis in non-irradiated mice
(unpublished), demonstrating the neuroprotective properties of pomegranate juice.
Pomegranate juice has higher polyphenolic contents than apple, black cherry,
Concord grape, cranberry, and pineapples juices (Dorsey & Greenspan, 2014). Research
suggests that the anti-inflammatory and antioxidant properties found in pomegranates can
be attributed to the synergistic effect of the multiple polyphenols found in the juice, peel,
pulp, and seeds. The whole juice has been found to have more anti-apoptotic properties
than any individual polyphenol substrate in pomegranates (Seeram et al., 2005). More
recently, pomegranate extract attenuated the release of a pro-inflammatory cytokine, TNF
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alpha, from microglial cells (Jung et al., 2006), validating the anti-inflammatory potential
of pomegranates. Altogether, research suggests that the polyphenols found in
pomegranates could be an effective therapy against inflammation in the brain. No studies
to date have looked at the protective effects of pomegranates in concussions and this fruit
may be beneficial in ameliorating the negative effects of brain injury.

Aims of the Study
The present study will analyze possible long-term behavioral and
neuropathological changes in adult male C57BL/6 mice following a mild concussive
brain injury (mCHI) or repeated concussive brain injury (rmCHI) at acute (1, 3, 5, and 7
dpi) and long-term (30 dpi) time points. In addition, the neuroprotective effects of
pomegranate juice against injury-induced deficits will be analyzed.

Aim 1
Explore the behavioral effects of mild concussions in adult male mice.
Hypothesis 1: Mice with repeated concussions will demonstrate greater behavioral
deficits compared to mice with single anesthesia and repeated anesthesia.
Hypothesis 2: Mice with repeated anesthesia will demonstrate greater behavioral deficits
compared to mice with single anesthesia.

Aim 2
Explore microglial activation after mild concussions.
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Hypothesis 1: Mice with concussions will have higher levels of activated microglia
compared to single anesthesia and repeated anesthesia mice.
Hypothesis 2: Mice with repeated anesthesia will have higher levels of activated
microglia compared to single anesthesia mice.

Aim 3
Explore the effects of diet on behavior and neuropathology following mild
concussions.
Hypothesis 1: Concussions will lead to deficits on behavioral tests, and pomegranate
juice will protect against these deficits.
Hypothesis 2: Concussions will lead to higher levels of activated microglia, and
pomegranate juice will protect against activation.
Hypothesis 3: Repeated anesthesia will lead to deficits on behavioral tests compared to
single anesthesia mice, and pomegranate juice will protect against these deficits.
Hypothesis 4: Repeated anesthesia will lead to higher levels of activated microglia, and
pomegranate juice will protect against activation.

Aim 4
Explore interactions between effects of mild concussions and diet on behavioral
and microglial activation, as well as behavioral/biomarker correlations.
Hypothesis 1: Microglial activation will be correlated with deficits in behavioral tests.
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CHAPTER TWO
METHODS

Experimental Design
Male C57BL/6 mice (3 months old) were separated into 5 groups
(pomegranate/no-pomegranate, anesthesia/double anesthesia/rmCHI), yielding a total of
6 groups (see Table 1). Twenty-two animals started the pomegranate juice diet
immediately and continued on this until time of sacrifice. The pomegranate juice was
administered in the animal’s drinking water at a 1:20 ratio. This concentration of
pomegranate juice reduced Alzheimer’s pathology and improved radiation induced
deficits (Dulcich et al., 2013; Hartman et al., 2006). Twenty animals did not receive the
pomegranate preparation, but instead received filtered drinking water as control
treatment. Water treatments continued until time of sacrifice.

Table 1. Animal group breakdown.
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Animals were allowed to acclimate in to the animal facility for 2 days following delivery.
After acclimation, animals started on either the pomegranate or control treatment. After 1
week, animals were subjected to anesthesia, repeated anesthesia (RA), or repeated closed
head injury (rmCHI). Thereafter, animals underwent a battery of behavioral tests at 1, 3,
5, 7-11 days post injury (dpi). These tests assessed cognitive, motor, and learning
abilities. After behavioral testing at 11 dpi, mice were deeply anesthetized with isoflurane
and perfused through the heart with 4% paraformaldehyde until euthanization. Once
euthanization was confirmed, brains were removed and placed in paraformaldehyde for
24 hours, then stored in saline until further tissue preparation or were removed and
immediately frozen in liquid nitrogen for protein analysis. See Figure 1 for timeline of
experimental design.

Figure 1. Timeline of the experimental design.
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Animals
All protocols and procedures were approved by the Institutional Animal Care and
Use Committee of Loma Linda University and complied with the principles and
procedures of the Guidelines for the Care and Use of Experimental Animals. Adult 3month-old male C57BL/6J mice (Jackson Laboratory, Bar Harbor, ME) were housed
individually in cages on a 12-hr light-dark cycle at constant temperature and humidity,
and fed ad libitum. All experimental animals were randomly assigned to groups that
included anesthesia (n=12), RA (n=15), or rmCHI (1 hit to each hemisphere spaced 3
days apart; n=15). See Table 1 for detailed group numbers.

Pomegranate Preparation
Pomegranate juice (PomWonderful) was diluted 1:20 into filtered water. Full
strength pomegranate juice consists of 84% water, 14% carbohydrates, 0.48% citric acid,
0.1% protein, 0.02% fat, and 1% other, including polyphenols (phenolic acids and
flavonoids). Phenolic acids include 115 ppm ellagic acid and 5 ppm gallic acid.
Flavonoids include 1880 ppm hydrolysable tannins (e.g. gallotannins, ellagitannins,
punicalagin) and 369 ppm anthocyanins, and their glycosides (e.g. cyanidin, delphinidin,
pelargonidin). PomWonderful pomegranate juice was purchased from local grocery
stores and kept refrigerated at 4° C throughout the experiment. The solution was prepared
as needed (as often as the animals’ water needed changing), and was administered by
diluting the solution into the animal’s drinking water. Animals had ad libitum access to
their water bottles. Animals that did not receive the pomegranate juice treatment received
filtered drinking water.
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Anesthesia
Mice were anesthetized (isoflurane: 3% induction and maintenance; Webster
Veterinary Supply, Inc., Sterling, MA) for 30 minutes in a chamber with a heating pad
that maintained body temperature at 37°C. Animals were placed in a recovery chamber
before they were returned to their home cages. Repeated anesthesia (RA) mice underwent
similar procedures with an additional anesthesia dose 3 days later.

Repeated Closed Head Brain Injury
Mice were deeply anesthetized with isoflurane (isoflurane: 3% induction, 1-2%
maintenance) and placed on a cushioned foam base (Foam to Size Inc., Ashland, VA).
Anesthesia was monitored throughout the surgery and body temperature was maintained
at 37C with a heating pad (except during injury). Lidocaine (0.01 mg/kg; dilution
0.01/mL) was injected subcutaneously for post-surgery pain relief from the surgical
procedure. Following a midline incision and retraction of the skin overlying the skull,
injury was induced to the right temporal-parietal cortex of the skull using a 4-mm
rounded plastic tip (Delrin) affixed to an electromechanical impactor (Leica
Microsystems Company, Richmond, IL). The injury was delivered using impact duration
of 200 milliseconds at a velocity of 4 m/sec and resulted in a rotational head
displacement of 2 mm. The center of the injury was located 2.5 mm below Bregma and
2.5 mm to the right of the Sagittal midline at ~9-11 angle, perpendicular to the cortical
surface. The surgical site was sutured after recording of any bleeding or fractures (n = 5).
Intraperitoneal buprenorphine (0.01 mg/kg; dilution 0.01/mL) injections were
administered to mice for post-surgery pain relief before the animals are returned to their
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home cages. Mice underwent similar surgical procedures with an additional injury over
the left temporal-parietal cortex 3 days after the initial impact. The center of the injury
was located 2.5 mm below Bregma and 2.5 mm to the left of the sagittal midline.

Behavioral Testing
Behavior was tested at 1, 3, 5, 7-11 dpi. All behavioral tests at each time point
were carried out within the 12-hour light cycle and groups were interleaved in testing
sequence. Experimenters blinded to the treatment groups completed testing. Tests
administered on 1, 3, 5, and 7 dpi were completed in the following order: open field, foot
fault, beam balance, and rotarod. Behavioral tests at 8-11 dpi were completed in the
following order: elevated zero maze, tail suspension, and water maze. The orders of tests
were determined based on the degree of difficulty, with easy tests administered first and
more rigorous, challenging tests administered last.

Open Field Activity
Open-field testing assessed general exploratory behavior and activity levels. Mice
were placed in a 49 cm x 36 cm opaque open-topped plastic bins and allowed to explore,
unrestricted, for the duration of 30 minutes. Movements of each animal was recorded by
an overhead camera and analyzed by a computerized tracking system (Noldus
Ethovision; Information Technology, Inc., Leesburg, VA). Various parameters were used
as a measure of overall activity level including total distance traveled, percentage of time
spent moving, percentage of time in the center, and percentage of time in the periphery.
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Beam Balance
Fine motor coordination and balance were assessed using the beam balance test.
A square acrylic glass beam balance (61 cm length, 0.65 cm width) labeled in 2.5-cm
increments was used. Mice were placed at the midpoint of the beam and were allowed to
walk unrestricted in either direction for 60 seconds. The number of falls, total time spent
on the beam, distance traveled, left and right turns, and the numbers of left or right paw
slips were recorded. Each animal was given 2 trials, approximately 30 min apart.

Rotarod
The accelerating rotarod is a test of sensorimotor coordination and balance that
consists of a 3-cm diameter rotating horizontal cylinder (Rotamex-5; Columbus
Instruments, Columbus, OH). Mice were placed on the cylinder and continuously walked
forward to avoid falling. Latency to fall was recorded. Mice were tested with three blocks
of two consecutive trials per day. Blocks consisted of two stationary trials (at 5 RPM
steady), two trials that started at 5 RPM and accelerated 3 RPM every 5 seconds, and two
trials that started at 5 RPM and accelerated 3 RPM every 3 seconds. Each trial lasted up
to 60 seconds with approximately 30 minutes between each block. Performance over
days of testing was used as a measure of motor learning.

Elevated Zero Maze
The elevated zero maze was used to assess exploratory behaviors in an anxietyprovoking environment. The maze consisted of a plastic ring, with a 100 cm outer
diameter, 10 cm wide. The two opposing quadrants were enclosed with 35 cm walls. The
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room was dimmed, and halogen lights directly illuminated the open spaces of the maze.
Animals were placed in the center of one of the open spaces and allowed to freely explore
the zero maze for 5 minutes. The percentage of time spent in the enclosed quadrants was
calculated. Spending time in the enclosed spaces is generally associated with anxiety-like
behavior.

Tail Suspension Test
The tail suspension test was administered to assess depression-like behaviors.
Mice were suspended by the tail with adhesive tape that was attached approximately 1.5
cm from the tip of the tail. The other end of the tape was wrapped around a hook that was
embedded in the center of the ceiling of a wooden box (19 cm x 21 cm x 40 cm). Once
suspended, the animal’s rostral end was approximately 20 cm from the floor of the box.
The box was enclosed on all sides except for the viewing side, and lighting and sound in
the room was kept at a minimum. Each animal received one 6-min trial and was rated on
mobility and agitation for the duration of 6 minutes. The time that the animal remained
immobile during the final 4 minutes of the trial was recorded. Immobility was defined as
the complete lack of movement by the mouse, even if it was swinging back and forth
from a previous struggle or if it is curled up while holding its paws (as long as it was not
struggling or moving otherwise).

Water Maze
Learning and memory was assessed with the water maze. This test of spatial
navigation required an animal to learn the location of a hidden platform in a pool of water
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using the visual cues from around the room. The water maze consisted of a metal pool
(110 cm diameter) filled with water that was colored opaque with white tempura paint.
The pool contained a moveable platform (11 cm diameter) that the animal could step onto
to escape the water. Animals were given a total of 10 trials per day for 5 consecutive
days. For each trial, animals were released into the pool, with their nose against the wall,
at one of the four release points and were allowed to swim to the platform. The trials
lasted a maximum of 60 seconds. If mice do not find the platform in the allotted time,
they were manually guided to the platform. An overhead camera recorded the swim
paths, which gathered data for the quantification of distance, latency, proximity to target,
and swim speed by a computerized tracking system (Noldus Ethovision). Cued learning,
which is a control task for assessing sensorimotor and/or motivational deficits that may
affect performance during the spatial phase, was assessed on day 1 of the water maze
protocol. The surface of the escape platform was visible (5 mm above the surface of the
water) and a pole was placed on top of the platform to make its location more obvious.
The location of the platform varied from trial to trial. Animals were released into the pool
opposite the location of the platform and will be allowed to remain on the platform for 5
seconds after finding it. As performance improves, escape latency and swim path length
generally decrease.
Spatial learning was assessed on days 2 and 3 of the water maze protocol. In this
phase of testing, the mice had to find the platform based on its relationship to the spatial
cues around the room, rather than direct visualization. The escape platform was
submerged 1 cm below the surface of the opaque water, and the location of the platform
was changed each day. After finding the platform, animals were allowed to remain on
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there for an additional 5 seconds. A probe trial was administered on day 3. In the probe
trial, the platform was removed from the pool, allowing the animal to search for the
platform for 60 seconds. The amount of time the animal spent in the probe quadrant was
measured as well as the total number of times the animal crossed over the former location
of the platform. After an hour, the platform was placed back into the pool at a new
location, and the next sets of 10 trials were administered.

Animal Euthanasia and Tissue Preparation
Mice were prepped for perfusions to have their brains used for
immunohistochemistry or western blot analysis after behavioral testing was completed
(11 dpi). Mice allotted to immunohistochemistry (n = 26) were deeply anesthetized with
isoflurane and perfused transcardially with 4% paraformaldehyde in phosphate buffered
saline (PBS). After euthanization, brains were extracted from the skull immediately and
immersed in 4% paraformaldehyde in 0.1 M PBS solution at 4º C for 24 hours.
Remaining mice (n = 16), were allotted to western blot analysis. These mice were deeply
anesthetized with isoflurane and perfused through the heart with PBS. Brains were
extracted and cut into 5 sections (left anterior cortex, right anterior cortex, left posterior
cortex, right posterior cortex, and cerebellum) over ice, frozen with liquid nitrogen, and
stored at -80º C for further processing. Additional mice (n = 8) were gifted from Dr.
André Obenaus to be used towards western blot analysis. These mice received dietary
treatment and injuries similar to other mice from this study, but did not undergo
behavioral testing. Mouse brains were processed as mentioned above.
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Western Blot
Western blotting is a technique used in cell and molecular biology to detect
specific proteins in a sample of tissue homogenate. Gel electrophoresis is used to separate
proteins by structure or length of the peptide. Proteins are then transferred to a membrane
and stained with antibodies specific to the target protein and visualized.

Protein Extraction
Brain were removed from -80º C, weighed, cut into 4-5 sections and placed in a
glass test tube that was kept over ice. 500 l of lysis buffer (10 mM Tris, pH 7.4, 100
mM sodium chloride, 1 mM ethylenediaminetetraacetic acid, 1 mM ethylene glycol
tetraacetic acid, 1% Triton X-100, 10% glycerol, 0.1% sodium dodecyl sulfate, 0.5%
deoxycholate) was added to each glass tube. Tissue was homogenized (pulverized;
TissueRuptor, Hilden, Germany) and contents were transferred to Eppendorf tubes
(FisherbrandTM, Waltham, MA) kept over ice. Cells were further lysed with 27 gauge
needles (BD PrecisionGlideTM, Franklin Lakes, NJ) and tubes were placed on a rotator at
4º C for 2 hours to further agitate cells. Tubes were placed in a centrifuge at 4º C and
spun at 12,000 rpm for 20 minutes. The supernatant (solution with cytosolic contents)
was removed and divided between aliquots and stored at -80º C. 250 l of lysis buffer
was added to each tube, mixed, and the contents were lysed with 27 gauge needles. Tubes
were placed in a centrifuge at 4º C and spun at 16,000 rpm for 30 minutes. The
supernatant was removed and divided between aliquots and stored at -80º C.
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Determination of Protein Concentration
To ensure that samples are in proper range of detection for the assay and can be
compared equally, the concentration of total protein in each sample must be determined.
A protein assay kit (PierceTM BCA protein assay kit; ThermoFisher Scientific; Waltham,
MA) was used to determine the total protein concentration for each sample. Samples
were removed from -80º C and placed on ice to thaw. Standard protein solutions (diluted
bovine serum albumin in PBS) were made to determine the linear range of the protein
assay and 10 l of each solution was added to one column of the 96-well plate. Since the
lysis buffer reacted with the BCA assay, diluted (1:2 or 1:5) lysis buffer was added to the
wells (3 wells per dilution) to correct protein absorbance values. Samples (supernatant)
were diluted (1:2 or 1:5) in PBS and 10 l was added into the wells using a pipette. To
correct for pipette variation and error, each sample was added a duplicate, meaning 2
wells with 10 l in each. Two hundred l of BCA solution was added to each well using
a pipette. The plate was placed on a warmer at 37º C for 15 minutes to accelerate the
chemical process (purple color) and placed into a cell absorption reader. The color
change that resulted was proportional to the amount of protein in the sample. The
absorbance of the lysate solution was set to 562 nm. Protein concentration is determined
by comparison of the target samples to a known standard. Values were extracted and the
standard curve was determined. The absorbance values for each sample and lysis buffer
were averaged. Absorbance values were determined and plotted on the equation
generated from the standard curve to yield the protein concentration of each sample.

32

Protein Determination
The western blot gel package was removed from 4º C and opened over the sink.
The tape and comb were removed and rinsed with dH20. The western blot chamber was
assembled and filled to the top with running buffer (20X MOPS + ddH20; used to
separate medium to large size proteins). The outer chambers were filled halfway with
running buffer. The samples of interest were removed from -80º C and placed on ice to
thaw. Based on the protein concentrations of each sample, the volumes of each sample
and PBS were calculated and added to an Eppendorf tube. Seven l of a master mix
(reducing agent and loading buffer) was added to the tubes to help denature and unfold
proteins. This was done to reveal the epitope site for antibodies to bind to. Total volume
of solution to load into the gel was 27 l per sample. The samples were heated for 15
minutes at 65º C and immediately placed on ice for 1 minute. A 10 l ladder was added
to the first lane. The ladder, also known as molecular weight markers, was a premade
mixture of proteins with known molecular weights that span a range from 10 kDa to 200
kDa. Ladders are used to determine the progress while the gel is running, checking
transfer efficiency, and for orienting the blot. Twenty-seven l of each sample was
loaded into a specific lane. The chamber ran on a power supply at 200 volts (400mA
current threshold) for 57 minutes.
Fifteen minutes before the gel was finished running, sponges were pre-soaked in
transfer buffer (methanol and transfer buffer). The PVDF membrane was soaked in
methanol alone for 2-3 minutes. The gel was removed from the case and floated into a
trap with transfer buffer. The transfer cassette was layered as follows: 2 sponges, filter
paper, gel, PVDF membrane, filter paper, and 3 sponges. Air bubbles were removed by
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rolling over with a pipette tip. The cassette was fitted and locked into the chamber and
transfer buffer was added to the inner chamber. The outer chambers were filled with
dH20 and placed on ice. The transfer occurred for 1 hour 45 minutes at 30 V (400mA
current threshold). The membrane was removed and placed in blocking for 1 hour in
TBST-M (tris-buffered saline, tween 20, and non-fat milk powder) to reduce non-specific
binding of the antibody. Primary antibodies (Iba1, Wako, Richmond, VA, dilution
1:1000; GFAP, EMD Millipore, Billerica, MA, dilution 1:1000) were added to the
primary buffer (TBST-M and TBST) and incubated overnight at 4º C on a rotator.
The next day, the membrane underwent 3- 10-minute washes in TBST and
blocked with TBST-M for 10 minutes. The secondary antibodies were added (dilution
1:5000) and incubated for 2 hours at room temperature. The membrane underwent 3- 10minute washes in TBST and imaged.
There have been several western blot experiments performed and analysis is
pending.

Statistical Analysis
All statistics were computed using IBM SPSS 21. After data screening and
preliminary analyses, it was determined that data would be appropriately analyzed as two
separate comparisons, not all three groups compared to one another, as double anesthesia
is the comparative sham for rmCHI. Thus, data was analyzed as injury (repeated
anesthesia, rmCHI) vs. treatment (control, pomegranate) and injury (anesthesia, repeated
anesthesia) vs. treatment (control, pomegranate).
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One-way ANOVA’s (Injury: Double Anesthesia/rmCHI; Anesthesia/Double
Anesthesia) and univariate ANOVA’s were conducted for all behavioral tests with 2
between subjects groups with two levels each (Injury: Repeated Anesthesia/rmCHI;
Anesthesia/Repeated Anesthesia, Treatment: Control/Pomegranate). Repeated measures
(Injury: Repeated Anesthesia/rmCHI; Anesthesia/Repeated Anesthesia vs. Test Day)
were conducted on OF, BB, FF, RR, and WM data. Swim data from the water maze will
be analyzed by averaging trials into 5 blocks of 2 trials each. Probe swim data will be
analyzed by averaging all trials. To control to sphericity and compound symmetry due to
repeated measures in the test-day (trials), the Greenhouse-Geisser correction to the
degrees of freedom was used to determine the p-value. In cases where normality was
violated, a square root transformation was conducted and run on the univariate ANOVA.
Correlations between behavioral and biological variables were determined using the
Pearson product-moment coefficient. An α-level of 0.05 will be used for all statistical
significance tests.
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CHAPTER THREE
RESULTS

Repeated Anesthesia (RA) vs. rmCHI
There were no weight or treatment differences between RA (M = 26.32, SD =
2.69; M = 275.67, SD = 75.78) and rmCHI (M = 27.58, SD = 2.03; M = 314.20, SD =
97.39) mice, respectively.

General Activity: Open Field
Generalized locomotor activity was recorded at 3, 5, and 7 dpi. There were no
differences in activity found between RA and rmCHI mice on days of testing, (Figure 2
and 3). Water treatment did not influence activity levels in RA or rmCHI mice
throughout days of testing (Figure 4 and 5).
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Figure 2. (A, B, C, D) There were no significant differences found between groups
across days of open field testing.

Figure 3. (A & B) There were no significant differences found between groups across
days of open field testing.
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Figure 4. (A, B, C, D) Pomegranate treatment did not affect exploratory activity levels
across days of testing in the open field test (p > .05).

Figure 5. (A & B) Pomegranate treatment did not affect exploratory activity levels across
days of testing in the open field test (p > .05).
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Motor Skill: Foot Fault
The foot fault test was administered 1, 3, 5, and 7 dpi in which the number of
faults and distance traveled were recorded. A repeated measures ANOVA was conducted
to analyze faults across days. Mauchly’s test indicated that the assumption of sphericity
had been violated 2(5) = 29.33, p = .00, therefore the degrees of freedom were corrected
using Greenhouse-Geisser estimates of sphericity ( = .62). Mice showed evidence of
faulting less across days, (F(1.87, 48.56) = 71.55, p = .00, partial 2 = .73, power = 1.00;
Figure 6A). There was a main effect of injury (F(1, 26) = 12.18, p = .00, partial 2 = .32,
power = .92; Figure 6A). Further analysis revealed that rmCHI mice displayed motor
deficits by faulting significantly more than RA mice on 1 dpi (F(1,28) = 6.57, p = .02)
and 3 dpi (Welch’s F(1,24.36) = 6.57, p = .02, 2 = .16; Figure 6A).
A repeated measures ANOVA was conducted to analyze distance across days of
testing. Mauchly’s test indicated that the assumption of sphericity had been violated 2(5)
= 27.93, p = .00, therefore the degrees of freedom were corrected using GreenhouseGeisser estimates of sphericity ( = .71). Mice showed evidence of faulting less across
days, (F(2.11, 54.96) = 8.36, p = .00, partial 2 = .24, power = .96; Figure 6B). There was
a main effect of injury (F(1, 26) = 5.79, p = .02, partial 2 = .18, power = .64; Figure 6B).
Further analysis revealed that rmCHI mice traveled a greater distance than RA mice at 3
dpi (F(1,28) = 5.95, p = .02).
A repeated measures ANOVA was conducted to analyze the percentage of faults
per distance across days of testing. Mice showed evidence of faulting less across days,
(F(3, 78) = 15.41, p = .00, partial 2 = .37, power = 1.00; Figure 6C). There was trend
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Figure 6. (A) Mice with repeated concussions faulted significantly more on 1 and 3 dpi
compared to repeated anesthesia mice (*p < .05). (B) Mice with repeated concussions
traveled significantly more on 3 dpi compared to repeated anesthesia mice (*p < .05). (C)
All mice reduced the percentage of faults per distance across days (p < .01).

towards a main effect of injury (p = .06); however these results did not reach statistical
significance (Figure 6C).
Pomegranate treatment did not reduce the number of faults (p > .05; Figure 7A),
distance (p > .05; Figure 7B), or the percentage of faults per distance across days of
testing (p > .05; Figure 7C).

40

Figure 7. (A, B, C) Pomegranate treatment did not affect performance in the foot fault
task (p > .05).

Motor Skill: Beam Balance
Motor skills and coordination were assessed with the beam balance at 1, 3, 5, and
7 dpi. Repeated measures ANOVA was conducted to analyze whether there were
differences in left sided slips across days. Mauchly’s test indicated that the assumption of
sphericity had not been violated 2(5) = 6.60, p = .25, therefore sphericity was assumed.
The number of left sided slips decreased across days of testing, (F(3, 78) = 4.04, p = .01,
partial 2 = .13, power = .82; Figure 8A).
Another repeated measure ANOVA was conducted to analyze whether there were
differences in right-sided slips across days. Mauchly’s test indicated that the assumption
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of sphericity had not been violated 2(5) = 10.31, p = .07, therefore sphericity was
assumed. The number of right-sided slips decreased across days of testing, (F(3, 78) =
6.88, p = .00, partial 2 = .21, power = .97; Figure 8B).
Repeated measure ANOVA was conducted to analyze whether there were
differences in distance traveled across days. Mauchly’s test indicated that the assumption
of sphericity had been violated 2(5) = 13.93, p = .02, therefore the degrees of freedom
were corrected using Greenhouse-Geisser estimates of sphericity ( = .76). The distance
mice traveled decreased across days of testing, (F(2.27, 58.95) = 3.32, p = .04, partial 2
= .11, power = .64; Figure 8C).
Mice did not differ in the number of times they fell off the beam across days of
testing (p > .05; Figure 8D).
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Figure 8. (A, B, C) Mice decreased the number of left-sided slips, right-sided slips, and
distance traveled across days of testing on the beam balance, regardless of injury (p <
.05). (D) Mice did not differ in the number of times they fell off the beam across days of
testing (p > .05).

Another repeated measure ANOVA was conducted to analyze whether there were
differences in left turns across days. Mauchly’s test indicated that the assumption of
sphericity had not been violated 2(5) = 7.12, p = .21, therefore sphericity was assumed.
The number of left turns decreased across days of testing, (F(3, 78) = 5.19, p = .00,
partial 2 = .17, power = .91; Figure 9A).
Another repeated measure ANOVA was conducted to analyze whether there were
differences in right turns across days. Mauchly’s test indicated that the assumption of
sphericity had not been violated 2(5) = 9.08, p = .11, therefore sphericity was assumed.
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The number of right turns decreased across days of testing, (F(3, 78) = 2.93, p = .04,
partial 2 = .10, power = .68; Figure 9B).

Figure 9. (A & B) Mice decreased the number of left turns and right turns across days of
testing on the beam balance, regardless of injury (p < .05).

Pomegranate treatment influenced performance in the beam balance. There was a
significant interaction between injury and treatment across days of left-sided slips,
(F(3,78) = 3.41, p = .02, partial 2 = .12, power = .75;Figure 10A). Further analysis
revealed a main effect of injury at 3 dpi (F(1,26) = 5.81, p = .02, partial 2 = .18, power
= .64; Figure 10A) and a significant interaction between treatment and injury at 5 dpi,
(F(1,26) = 5.95, p = .02, partial 2 = .19, power = .65; Figure 10E). rmCHI mice on the
pomegranate treatment made fewer left-sided slips compared to those on the control diet,
whereas RA mice on the control diet made fewer left-sided slips compared to those on
the pomegranate treatment (Figure 10E). The pomegranate treatment seemed to improve
performance in rmCHI mice.
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Pomegranate treatment did not influence right-sided slips (p > .05; Figure 10B).
There was a significant interaction between injury and treatment across days of testing,
(F(2.27, 58.95) = 3.52, p = .03, partial 2 = .12, power = .67; Figure 10C). Further
analysis revealed that pomegranate treatment reduced deficits in rmCHI mice and
induced deficits in RA mice at 5 dpi, (F(1,26) = 3.13, p = .09, partial 2 = .11, power =
.40; Figure 10F). Pomegranate treatment did not influence falls on the beam balance (p >
.05; Figure 10D).

Figure 10. (A) Injured mice made more left-sided slips compared to controls at 3 dpi,
regardless of diet (**p < .05). There was a significant interaction at 5 dpi (*p < .05). (B)
Pomegranate treatment did not influence right-sided slips across days of testing on the
beam balance (p > .05). (C) Pomegranate treatment may negatively impact beam balance
performance in RA mice at 5 dpi, but may improve performance in rmCHI mice. (D)
Pomegranate treatment did not influence the number of falls across days of testing (p >
.05).
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Figure 10E. Pomegranate treatment significantly influenced performance on the beam
balance in rmCHI mice at 5 dpi. Injured mice on the pomegranate treatment made fewer
left-sided slips compared to those on the control diet, whereas RA mice on the control
diet made fewer left-sided slips compared to those on the pomegranate treatment (p <
.05).

Figure 10F. Pomegranate treatment may negatively impact beam balance performance in
RA mice at 5 dpi, but may improve performance in rmCHI mice.
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Pomegranate treatment did not influence the number of left turns or right turns
made across days of testing (p > .05; Figure 11 A and B, respectively).

Figure 11. (A & B) Pomegranate treatment did not influence the number of left or right
turns mice made across days of testing (p > .05).

Motor Skill: Rotarod
Rotarod performance was assessed at 1, 3, 5, and 7 dpi. Repeated measures
ANOVA was conducted to analyze whether there were differences in performance during
the steady speed (5 rpm) across days. Mauchly’s test indicated that the assumption of
sphericity had been violated 2(5) = 12.23, p = .03, therefore the degrees of freedom were
corrected using Greenhouse-Geisser estimates of sphericity ( = .80). Performance on the
rotarod improved across days of testing, regardless of injury; (F(2.40, 67.31) = 33.93, p =
.00, partial 2 = .55, power = 1.00; Figure 12A). There were no main effects or
significant interactions. Another repeated measures ANOVA was conducted to analyze
whether there were differences in performance testing during the more challenging speed
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where 3 rpm would increase every 5 seconds (accelerating) across days. Mauchly’s test
indicated that the assumption of sphericity had not been violated 2(5) = 6.95, p = .23.
Performance on the rotarod improved across days of testing, regardless of injury; (F(3,
84) = 9.08, p = .00, partial 2 = .25, power = 1.00; Figure 12B). There were no main
effects or significant interactions. Another repeated measures ANOVA was conducted to
analyze whether there were differences in performance testing during the most
challenging speed where 5 rpm would increase every 3 seconds (fast) across days.
Mauchly’s test indicated that the assumption of sphericity had not been violated 2(5) =
1.91, p = .86. Performance on the rotarod improved across days of testing, regardless of
injury; (F(3, 84) = 12.68, p = .01, partial 2 = .13, power = .85; Figure 12C). There were
no main effects or significant interactions.
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Figure 12. (A, B, C) Mice improved their performance on the rotarod test across days of
testing, regardless of injury (p < .05).

Pomegranate treatment did not influence performance across days of testing
(Figure 13).
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Figure 13. (A, B, C) Pomegranate treatment did not improve motor performance in the
steady, accelerating, or fast trials of the rotarod, (p > .05)

Anxiety-like Behavior
Anxiety-like behavior was assessed with the elevated zero maze. RA mice and
rmCHI mice did not differ in the percentage of time spent in the darker quadrants
(anxiety behavior; (p > .05; Figure 14A). RA mice also did not differ in the percentage of
time spent in the darker quadrants (p > .05; Figure 14B).
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Figure 14. (A & B) RA and rmCHI mice did not differ in the percentage of time spent in
the darker quadrants or lighter quadrants in the elevated zero maze test (p > .05).

Water treatment did not affect RA or rmCHI mice in the percentage of time spent
in the darker or lighter quadrants, (Figure 15 A & B, respectively).

Figure 15. (A & B) Water treatment did not affect the percentage of time spent in the
darker quadrants or lighter quadrants in the elevated zero maze test, (p > .05).
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Depression-like Behaviors
Depression-like behaviors were assessed with the tail-suspension test. RA and
rmCHI mice did not differ in the time they first stopped struggling (latency; Figure 16A)
or the time they spent mobile after the first latency (Figure 16B). RA and rmCHI also did
not differ in the percentage of time they spent immobile in the test (Figure 16C). Thus,
neither group exhibited depression-like behaviors.

Figure 16. (A, B, C) RA and rmCHI mice did not differ in latency, mobility after latency,
or the percentage of time spent immobile in the tail suspension test (p > .05).

Pomegranate treatment did not affect latency or mobility after the first latency
(Figure 17 A & B, respectively). Percentage of time spent immobile failed to meet
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assumptions of equal variances for the factorial ANOVA. To better understand the
relationship between treatment and injury groups on these variables, a square root
transformation was applied, however, failed to correct for the assumptions that were not
previously met. There was a trend towards a significant interaction between treatment
and injury in percentage of time mice spent immobile, (F(1,26) = 2.88, p = .10, partial 2
= .10, power = .37; Figure 17C). The control treatment may have reduced depression-like
behavior in rmCHI mice, whereas the pomegranate treatment may have made rmCHI
more depressed, (F(1,26) = 3.52, p = .08; Figure 17C).

Figure 17. (A & B) Pomegranate treatment did not reduce depression-like behaviors on
the tail suspension test (p > .05). (C) rmCHI mice on the pomegranate treatment trended
towards worse performance, compared to rmCHI mice on the control treatment (#p <
.10).
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Learning/Memory
Learning and memory were assessed with the water maze. A repeated measures
ANOVA was conducted to analyze cued water maze performance across blocks.
Mauchly’s test indicated that the assumption of sphericity had been violated 2(9) =
59.09, p = .00, therefore the degrees of freedom were corrected using GreenhouseGeisser estimates of sphericity ( = .46). Mice showed evidence of learning the locations
of the visible platform during the cued training water maze trials by finding the platform
quicker across blocks, (F(1.82, 51.08) = 32.08, p = .00, partial 2 = .53, power = 1.00;
Figure 18A). There were no significant differences in performance between RA and
rmCHI mice in the cued water maze (Figure 18A).
Overall, mice spent less time searching for the submerged platform across blocks
in the spatial 1 water maze (F(4, 112) = 4.98, p = .00, partial 2 = .15, power = .96;
Figure 18B), however, significant deficits emerged in rmCHI mice by block 5, (Welch’s
F(1,16.63) = 8.98, p = .01, 2 = .21; Figure 18B).
RA and rmCHI mice showed evidence of learning the new location of the
submerged platform across blocks on spatial day 2, (F(4, 112) = 13.63, p = .00, partial 2
= .33, power = 1.00; Figure 18C).
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Figure 18. (A) RA and rmCHI mice did not differ in amount of time to locate the visible
platform during the cued water maze (p > .05); however, all mice learned the location of
the platform by block 5 (p < .05). (B) RA mice showed evidence of learning the location
of the submerged platform on the spatial 1 water maze, whereas rmCHI mice showed no
evidence of locating the platform by block 5 (*p < .05). (C) Both RA and rmCHI mice
showed evidence of learning the location of the submerged platform on day 2 of the
spatial water maze.

Further analysis revealed differences in swim behavior, such that 95% confidence
intervals indicated that RA mice had a significant tendency to swim to the left while
searching for the submerged platform (p < .05, Figure 19C). There were no differences in
swim behavior in the cued, spatial 1, or in probe water maze trials (p > .05; Figure 19A,
B, & D).
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Figure 19. (A, B, & D) There were no differences in swim behavior in the cued, spatial
1, or probe water maze, respectively (p > .05). (C) In day 2 of the spatial water maze, RA
mice tended to swim to the left compared to rmCHI mice (*p < .05; mean +/- 95% CI).

A repeated measures ANOVA was conducted to analyze the effects of injury and
treatment in water maze performance in the cued trials. Mauchly’s test indicated that the
assumption of sphericity had been violated 2(9) = 58.01, p = .00, therefore the degrees
of freedom were corrected using Greenhouse-Geisser estimates of sphericity ( = .45).
Mice showed evidence of learning the locations of the visible platform during the cued
training water maze trials by finding the platform quicker across blocks, (F(1.80, 46.82)
= 30.78, p = .00, partial 2 = .54, power = 1.00; Figure 20A). Pomegranate treatment did
not affect water maze performance in the cued trials (Figure 20A).
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Spatial 1 water maze performance improved across blocks, (F(4, 104) = 5.02, p =
.00, partial 2 = .16, power = .96; Figure 20B). In addition, performance of each injury
group differed across blocks, (F(4, 104) = 2.99, p = .02, partial 2 = .10, power = .78;
Figure 20B). These differences became statistically significant in block 5, (F(3, 26) =
3.39, p = .03). Tukey’s HSD post hoc analysis revealed that pomegranate treatment
impaired performance in rmCHI mice, taking took longer to find the platform compared
to RA mice on the control (p < .05) and pomegranate (#p = .06) treatments. There were
no differences between rmCHI and water treatments.
Mice improved performance across blocks (F(4, 104) = 12.96, p = .00, partial 2
= .33, power = 1.00; Figure 20C), though treatment and injury did not interact with
spatial 2 water maze performance. Data from the probe trial revealed no significant
differences. Both RA and rmCHI mice swam the maze at random, spending a similar
amount of time in each quadrant.
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Figure 20. (A) Mice learned the location of the visible platform by block 5 (p < .01);
however, water treatment did not influence performance in the cued water maze. (B)
Performance in the spatial 1 water maze improved across blocks; however, deficits began
to emerge in rmCHI nice with pomegranate treatment by block 5. rmCHI mice with the
pomegranate treatment took longer to find the submerged platform than RA mice on the
control treatment (*p < .05) and pomegranate treatment (#p = .06). (C) Treatment and
injury did not interact with performance in day 2 of the spatial water maze. All mice
improved in locating the submerged platform by block 5.
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Table 2. Summary of significant behavioral findings and their associated p-values.
Test
Foot Fault

Summary of Significant Behavioral Findings
rmCHI faulted more than RA at 1 dpi

< .03

rmCHI faulted more than RA at 3 dpi

< .03

rmCHI traveled a greater distance than RA at 3 dpi

< .04

Beam Balance rmCHI made more left-sided slips at 3 dpi

Water Maze

p-value

< .03

rmCHI with pomegranate treatment made fewer left-sided
slips than RA at 5 dpi

< .03

RA with control treatment made fewer left sided slips than
RA with pomegranate treatment at 5 dpi

< .03

rmCHI mice with pomegranate treatment traveled less than
RA with pomegranate treatment at 5 dpi

< .04

rmCHI mice took longer to find the platform in spatial 1

< .02

rmCHI mice with pomegranate treatment took longer to find
the platform in spatial 1 than rmCHI on control treatment

< .05

RA mice had left turn bias in spatial 2

< .05

Behavioral Correlations
rmCHI mice with pomegranate treatment had both increased depression-like
behaviors and motor deficits across tests. Specifically, rmCHI mice that consumed more
of the pomegranate treatment spent a higher percentage of time immobile in the tail
suspension test, suggesting increased depression-like symptoms from pomegranates, r =
.84, p = .01 (Figure 21). rmCHI pomegranate treatment mice that had increased activity
in the open field also increased the distance explored in the foot fault test, r = .71, p = .05
(Figure 22). Pomegranate treated rmCHI mice that traveled the beam balance more spent
less time searching for the platform in the target quadrant in the probe water maze, r = -

59

.74, p = .04 (Figure 23). Lastly, rmCHI mice treated with pomegranate that took longer to
first give up (latency) in the tail suspension test also spent more time in the darker
quadrants in the elevated zero maze (r = .82, p = .01; Figure 24), indicative of normal
behavior.

Figure 21. rmCHI mice that consumed more of the pomegranate treatment spent a higher
percentage of time immobile in the tail suspension test, p < .01.
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Figure 22. Pomegranate treated rmCHI mice that had increased activity in open field
testing also had increased exploratory behavior in the foot fault test, p = .05.

Figure 23. Pomegranate treated rmCHI mice that had reduced activity in the beam
balance spent more time in the target quadrant during the probe water maze trial, p < .05.
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Figure 24. Pomegranate treated rmCHI mice that too longer to fist give up in the tail
suspension test also spent more time in the darker quadrants in the elevated zero maze, p
< .05.

Interestingly, the pomegranate treatment seemed to improve motor performance
in RA mice across tests. Mice that consumed more pomegranate treatment had a
reduction in the number of faults per distance in the foot fault test, r = -.71, p = .05
(Figure 25). More pomegranate treatment consumption in RA mice also led to better
average performance on the rotarod (stayed on the test longer), especially in the most
challenging speed of the test, r = .73, p = .04 (Figure 26). In addition, pomegranate
treated RA mice that spent more time in the perimeter of open field had better
performance on the rotarod, especially in the most challenging speed of the test, r = .74, p
= .04 (Figure 27).
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Figure 25. RA mice that consumed more pomegranate treatment made fewer faults in
the foot fault test, p = .05.

Figure 26. RA mice that consumed more pomegranate treatment had improved
performance on average in the most challenging rotarod trials, p = .05.
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Figure 27. Pomegranate treated RA mice that spent more time in the periphery in open
field testing had improved performance on average in the most challenging rotarod trials,
p < .05.

Anesthesia (SA) vs. Repeated Anesthesia (RA)
There were no weight or treatment differences between SA (M = 26.95, SD =
2.53; M = 270.92, SD = 63.50) and RA (M = 26.32, SD = 2.69; M = 275.67, SD = 75.78)
mice, respectively.

General Activity: Open Field
Generalized locomotor activity was recorded at 3, 5, and 7 dpi. Repeated
measures ANOVA was conducted and Mauchly’s test indicated that the assumption of
sphericity had not been violated and equal variances was assumed. There were no
differences in activity found between SA and RA mice across days of testing, (Figure 28,
Figure 29A). Both SA and RA mice increased rearing behavior across days of testing,
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(F(2, 28.41) = 11.85, p = .00, partial 2 = .24, power = .99; Figure 29B), that may have
indicative of anxiety-like behavior.

Figure 28. (A, B, C, D) There were no significant differences found between groups
across days of open field testing (p > .05).
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Figure 29. (A) SA and RA mice did not differ in the percentage of time they spent
exploring the test (p > .05). (B) SA and RA mice increased rearing behavior across days
of open field testing (p < .01).

Water treatment did not influence the percentage of time mice spent in the center,
periphery, distance traveled, or velocity across days of testing, (p > .05; Figure 30).
Water treatment also did not influence the distance traveled or rearings across days of
testing, (p > .05; Figure 31).
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Figure 30. (A, B, C, D) There were no significant differences found between groups
across days of open field testing (p > .05).

Figure 31. (A & B) There were no significant differences found between groups across
days of open field testing (p > .05).
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Motor Skill: Foot Fault
The foot fault test was administered 1, 3, 5, and 7 dpi in which the number of
faults and distance traveled were recorded. A repeated measures ANOVA was conducted
to analyze the effects of anesthesia on the number of faults. Mauchly’s test indicated that
the assumption of sphericity had been violated 2(5) = 15.15, p = .01, therefore the
degrees of freedom were corrected using Greenhouse-Geisser estimates of sphericity ( =
.78). Overall, mice reduced the number of faults across days of testing, (F(2.35, 54.00) =
68.88, p = .00, partial 2 = .75, power = 1.00; Figure 32A). There were no significant
main effects or interactions.
Another repeated measure ANOVA was conducted to analyze the effects of
anesthesia on the distance traveled in the foot fault test. Mauchly’s test indicated that the
assumption of sphericity had been violated 2(5) = 14.45, p = .01, therefore the degrees
of freedom were corrected using Greenhouse-Geisser estimates of sphericity ( = .76).
Overall, mice reduced the number of faults across days of testing, (F(2.27, 52.25) =
21.28, p = .00, partial 2 = .48, power = 1.00; Figure 32B). There were no significant
main effects or interactions.
Another repeated measures ANOVA was conducted to analyze the effects of
anesthesia on the percentage of faults per distance. Mauchly’s test indicated that the
assumption of sphericity had not been violated and equal variances were assumed. Mice
reduced the percentage of faults per distance across days of testing, (F(3, 69) = 12.61, p =
.00, partial 2 = .35, power = 1.00; Figure 32C). There were no significant main effects or
interactions.
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Figure 32. (A) SA and RA mice reduced faults across days of foot fault testing (p < .01).
(B) SA and RA mice traveled a shorter distance across days of testing (p < .01). (C) SA
and RA mice made fewer faults per distance across days of testing (p < .01).

Pomegranate treatment did not reduce the number of faults (p > .05; Figure 33A),
distance (p > .05; Figure 33B), or the percentage of faults per distance across days of
testing (p > .05; Figure 33C).
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Figure 33. (A, B, C) Water treatment did affect performance in the foot fault test (p >
.05).

Motor Skill: Beam Balance
Motor skills and coordination were assessed with the beam balance at 1, 3, 5, and
7 dpi. Overall, RA mice trended towards motor deficits with more left sided slips
compared to SA mice, (F(1,25) = 3.20, p = .09; Figure 34A).
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Figure 34A. RA mice trended towards more left sided slips compared to SA mice in the
beam balance, (p = .09).

A repeated measures ANOVA was conducted to investigate whether anesthesia
affected left-sided slips. Mauchly’s test indicated that the assumption of sphericity had
been violated 2(5) = 13.67, p = .02, therefore the degrees of freedom were corrected
using Greenhouse-Geisser estimates of sphericity ( = .70). Overall, mice reduced the
number of left-sided slips across days of testing, (F(2.11, 48.51) = 4.92, p = .01, partial

2 = .18, power = .80; Figure 35A). There were no significant main effects or
interactions.
Another repeated measures ANOVA was conducted to investigate whether
anesthesia affected right-sided slips. Mauchly’s test indicated that the assumption of
sphericity had been violated 2(5) = 13.82, p = .02, therefore the degrees of freedom were
corrected using Greenhouse-Geisser estimates of sphericity ( = .74). Overall, mice
reduced the number of right-sided slips across days of testing, (F(2.23, 51.27) = 4.64, p =
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.01, partial 2 = .17, power = .79; Figure 35B). There were no significant main effects or
interactions.
Another repeated measures ANOVA was conducted to investigate whether
anesthesia influenced the distance mice traveled in the beam balance. Mice did not differ
in the distance traveled across days of testing (p > .05; Figure 35C). There were no
significant main effects or interactions.
Another repeated measures ANOVA was conducted to investigate whether
anesthesia affected the number of times mice fell off the beam. Mice did not differ in the
number of times they fell off the test (p > .05; Figure 35D). Also, there were no
significant main effects or interactions.
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Figure 35. (A) Mice made fewer left-sided slips across days of testing on the beam
balance (p < .05). (B) Mice made fewer right-sided slips across days of testing (p < .05).
(C) Mice did not differ in the distance traveled across days of testing (p > .05). (D) Mice
did not differ in the number of times they fell off the beam across days of testing (p >
.05).

A repeated measures ANOVA was conducted to investigate whether anesthesia
affected left turns on the beam balance. Mice reduced the number of left turns across days
of testing, (F(3, 69) = 4.23, p = .01, partial 2 = .16, power = .84; Figure 36A). There
were no significant main effects or interactions.
Another repeated measures ANOVA was conducted to investigate whether
anesthesia affected right turns on the beam balance. Mice did not differ in the number of
right turns made across days of testing, (p > .05; Figure 36B).
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Figure 36. (A) Mice made fewer left turns across days of testing on the beam balance (p
< .05). (B) Mice did not differ in the number of right turns across days of testing (p <
.05).

Pomegranate treatment and anesthesia did not affect performance in the beam
balance (p > .05; Figure 37 & 38).
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Figure 37. (A, B, C, D) Water treatment did affect performance in the beam balance test
(p > .05).

Figure 38. (A & B) Water treatment did affect performance in the beam balance test (p >
.05).
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Motor Skill: Rotarod
Rotarod performance was assessed at 1, 3, 5, and 7 dpi with repeated measures
ANOVAs. Mauchly’s test indicated that the assumption of sphericity had not been
violated. Performance on the rotarod improved (mice stayed on longer) across days of
testing in the steady rotarod trials, (F(3, 69) = 34.50, p = .00, partial 2 = .60, power =
1.00; Figure 39A). There were no significant main effects or interactions.
A repeated measures ANOVA was conducted to analyze the effects of anesthesia
and motor performance in the accelerating rotarod trials. Mauchly’s test indicated that the
assumption of sphericity had been violated 2(5) = 18.25, p = .00, therefore the degrees
of freedom were corrected using Greenhouse-Geisser estimates of sphericity ( = .63).
Overall, mice improved across days of testing, (F(1.88, 43.32) = 5.45, p = .01, partial 2
= .19, power = .81; Figure 39B). There were no significant main effects or interactions.
Another repeated measures ANOVA was conducted to analyze the effects of
anesthesia and motor performance in the fast rotarod trials. Mauchly’s test indicated that
the assumption of sphericity had been violated 2(5) = 12.91, p = .02, therefore the
degrees of freedom were corrected using Greenhouse-Geisser estimates of sphericity ( =
.71). Overall, mice improved across days of testing, (F(2.12, 48.84) = 3.84, p = .03,
partial 2 = .14, power = .69; Figure 39C). There were no significant main effects or
interactions.
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Figure 39. (A, B, C) Mice improved their performance on the rotarod test across days of
testing, regardless of injury (p < .05).

Water treatment did not influence performance in the rotarod across days of
testing (Figure 40; p > .05).
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Figure 40. (A, B, C) Water treatment did not influence performance in the rotarod across
days of testing (p > .05).

Anxiety-like Behavior
Anxiety-like behavior was assessed with the elevated zero maze. Mice did not
differ in the amount of time spent in the darker quadrants of the maze (p > .05; Figure
41A). SA mice trended towards spending higher percentages of time in the lit quadrants
compared to RA mice, suggesting more anxiety-like and risk taking behaviors, (Welch’s
F(1,15.69) = 4.01, p = .06, 2 = .10; Figure 41B).
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Figure 41. (A) Mice did not differ in the amount of time spent in the darker quadrants of
the elevated zero maze test. (B) SA mice trended towards more risk taking and anxietylike behaviors compared to RA mice in the elevated zero maze test (#p = .06).

A factorial ANOVA was used to test the relationship between treatment and
anesthesia on anxiety-like behaviors. Anesthesia and pomegranate treatment did not
influence anxiety-like behaviors (time mice spent in the darker quadrants; p > .05; Figure
42A). However, there was a trend towards a main effect of anesthesia in the time spent in
the lit quadrants, (F(1,23) = 4.17, p = .05, partial 2 = .15, power = .50; Figure 42B), but
no significant interaction was found.
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Figure 42. (A) Anesthesia or treatment did not influence the percentage of time mice
spent in the darker quadrants in the elevated zero maze test (p > .05). (B) SA mice
trended towards spending more time in the lit quadrants, regardless of diet, compared to
RA mice in the elevated zero maze test.

Depression-like Behaviors
Depression-like behaviors were assessed with the tail-suspension test. SA and RA
mice did not differ in latency (time when they first gave up; p > .05; Figure 43A), the
time spent mobile after latency (p > .05; Figure 43B), total time spent immobile (p > .05;
Figure 43C), or the percentage of time they spent immobile in the test (Figure 43D).
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Figure 43. (A, B, C, D) SA and RA mice did not differ in depression-like behavior in the
tail suspension test (p > .05).

Water treatment did not influence latency (p > .05; Figure 44A), mobility after
latency (p > .05; Figure 44B), total time mice spent immobile (p > .05; Figure 44C), or
the percentage of time mice spent immobile (p > .05; Figure 44D).
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Figure 44. (A, B, C, D) Water treatment did not influence depressive-like behaviors in
the tail suspension test (p > .05).

Learning/Memory
Learning and memory were assessed with the water maze. A repeated measures
ANOVA was conducted to analyze cued water maze performance across blocks.
Mauchly’s test indicated that the assumption of sphericity had been violated 2(9) =
42.92, p = .00, therefore the degrees of freedom were corrected using GreenhouseGeisser estimates of sphericity ( = .51). Mice showed evidence of learning the locations
of the visible platform during the cued training water maze trials by finding the platform
quicker across blocks, (F(2.05, 51.36) = 30.14, p = .00, partial 2 = .55, power = 1.00;
Figure 45A). There were no significant main effects or interactions.
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In the spatial 1 water maze, mice showed evidence of learning the location of the
submerged platform across blocks, (F(4, 100) = 2.89, p = .03, partial 2 = .10, power =
.76; Figure 45B). Additionally, there was a trend towards a significant interaction
between anesthesia group and blocks, (F(4, 100) = 2.28, p = .07, partial 2 = .08, power =
.65; Figure 45B). Tukeys’s HSD post hoc analysis revealed that RA mice found the
location of the platform much faster by block 4 (p = .10) and block 5 (p < .05), whereas
SA mice did not learn the location of the platform at all.
SA and RA mice showed evidence of learning the new location of the submerged
platform across blocks on spatial day 2, (F(4, 100) = 4.50, p = .00, partial 2 = .15, power
= .93; Figure 45C). RA mice trended towards taking more time to find the submerged
platform on block 1 (F(1, 25) = 3.35, p = .08), but these deficits were reversed by block
5, (F(1, 25) = 3.17, p = .09).
There were no significant differences in the probe trial between SA and RA mice.
Both SA and RA mice swam the maze at random, spending a similar amount of time in
each quadrant (p > .05).
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Figure 45. (A) SA and RA mice did not differ in amount of time to locate the visible
platform during the cued water maze (p > .05); however, all mice learned the location of
the platform by block 5 (p < .05). (B) All mice appeared to learn the location of the
submerged platform in the spatial 1 water maze (p < .05); however, there was a strong
group effect by block 4. RA mice found the platform faster on block 4 (p < .10) and 5 (p
< .05), compared to SA mice that did not seem to learn the location at all. (C)
Performance in the spatial 2 water maze improved across blocks (p < .05). Interestingly,
RA mice trended towards longer to find the submerged platform on block 1 (#p = .08);
however, they trended towards finding the platform faster than SA mice by block 5 (#p =
.09).

There were no differences in swim behavior (turn bias) between SA and RA mice
in the water maze, (p > .05; Figure 46).
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Figure 46. (A, B, C) SA and RA mice did not differ in turn bias in the water maze (p >
.05).

Another repeated measures ANOVA was conducted to measure the influence
treatment and anesthesia had on cued water maze performance. Mauchly’s test indicated
that the assumption of sphericity had been violated 2(9) = 38.94, p = .00, therefore the
degrees of freedom were corrected using Greenhouse-Geisser estimates of sphericity ( =
.52). Mice showed evidence of learning the locations of the visible platform during the
cued training water maze trials by finding the platform quicker across blocks, (F(2.06,
47.48) = 29.26, p = .00, partial 2 = .56, power = 1.00; Figure 47A). There were no
significant interactions between anesthesia group and water treatment on performance
(Figure 47A).
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Another repeated measures ANOVA was conducted to measure the influence
treatment and anesthesia group had on spatial 1 water maze performance. There was a
main effect of learning the location of the submerged platform across blocks, (F(4, 92) =
2.99, p = .02, partial 2 = .12, power = .78; Figure 47B), and there were trends towards a
significant interactions between anesthesia group and blocks (F(4, 92) = 2.35, p = .06,
partial 2 = .09, power = .66) and treatment and blocks, (F(4, 92) = 2.28, p = .06, partial

2 = .10, power = .67). Tukey’s HSD post hoc analysis revealed that SA mice on the
pomegranate treatment took longer to find the platform than SA mice on the control
treatment (p = .08), RA mice on the control treatment (p < .05), and RA mice on the
pomegranate treatment (p < .05) by block 5 of the spatial 1 water maze. Thus,
pomegranate treatment led to learning and memory impairments in SA mice.
Another repeated measures ANOVA was conducted to measure the influence
treatment and injury had on spatial 2 water maze performance. There was a main effect of
blocks, where mice showed evidence of learning the location of the submerged platform
across blocks, (F(4, 92) = 4.48, p = .00, partial 2 = .16, power = .93; Figure 47C). There
was a trend towards significant differences between the groups on block 3, (F(3, 23) =
2.63, p = .07). Tukey’s HSD post hoc analysis revealed that pomegranate treatment
impaired performance of SA mice, taking longer to locate the submerged platform than
SA mice on the control treatment (p = .05). There were no significant interactions found.
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Figure 47. (A) Water treatment did not influence the amount of time SA and RA mice
took to locate the visible platform during the cued water maze (p > .05); however, all
mice learned the location of the platform by block 5 (p < .05). (B) Performance in the
spatial 1 water maze improved across blocks; however, deficits began to emerge in SA
mice with the pomegranate treatment by block 5. SA mice with the pomegranate
treatment took longer to find the submerged platform than SA mice on the control
treatment (*p < .10), RA mice on the control treatment (*p < .05), and RA mice on the
pomegranate treatment (*p < .05). (C) Performance in the spatial 2 water maze improved
across blocks (p < .05). Interestingly, SA mice on the pomegranate treatment trended
towards taking longer to find the submerged platform on block 3 compared to SA mice
on the control treatment (#p = .05).

A factorial ANOVA was conducted to determine whether treatment and injury
influenced probe water maze performance. There was a trend towards a significant
interaction between injury and treatment on the distance moved in the probe water maze,
(F(1, 23) = 3.67, p = .07, power = .45; Figure 48A). Pomegranate treatment may have
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impaired performance in SA mice, causing mice to search for the platform longer
compared to SA mice on the control treatment and RA mice on the pomegranate
treatment.

Figure 48A. There was a trend towards a significant interaction (p = .07) such that SA
mice on the pomegranate treatment may have searched for the platform longer compared
to SA mice on the control treatment and RA mice on the pomegranate treatment.
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Table 3. Summary of behavioral findings and their associated p-values.
Test

Summary of Behavioral Findings

Beam Balance Overall, RA trended towards more left-sided slips than SA
at 5 dpi

p-value
< .10

Zero Maze

SA spent more % of time in the lighter quadrants than RA

< .07

Water Maze

SA took longer to find the platform than RA in spatial 1

< .07

SA with pomegranate treatment took longer to find the
platform in spatial 1
SA took longer to find the platform in block 5 of spatial 2

< .05

SA with pomegranate treatment swam farther than RA with
pomegranate treatment

< .09
< .08

Behavioral Correlations
Surprisingly, the pomegranate treatment seemed to have adverse effects leading to
more risk-taking (anxiety-like) and depression-like behaviors in anesthesia mice. SA
mice that consumed more of the pomegranate treatment spent a higher percentage of time
immobile in the tail suspension test, suggesting increased depression-like symptoms from
pomegranates, r = .91, p = .01 (Figure 49). Also, SA mice that consumed more of the
pomegranate treatment spent a higher percentage of time in the lit quadrants of the
elevated zero maze (r = .87, p = .02; Figure 50), suggesting anxiety-like and risk taking
behaviors.
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Figure 49. SA mice that consumed more of the pomegranate treatment spent a higher
percentage of time immobile in the tail suspension test, p < .05.

Figure 50. SA mice that consumed more of the pomegranate treatment spent a higher
percentage of time in the lit quadrants in the elevated zero maze, p < .05.
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There was a couple of interesting motor performance related correlations as well.
Pomegranate treated SA mice that faulted more on average in the foot fault test, spent
less time immobile in the tail suspension test, r = -.82, p = .05 (Figure 51). In addition,
pomegranate treated mice that performed better on average in steady rotarod trials spent
more time immobile in the tail suspension test, r = .84, p = .04 (Figure 52).

Figure 51. Pomegranate treated SA mice that faulted more in the foot fault spent less
time immobile in the tail suspension test, p < .05.
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Figure 52. Pomegranate treated SA mice that performed better in the steady rotarod trials
spent more time immobile in the tail suspension test, p < .05.

Interestingly, the pomegranate treatment seemed to improve motor performance
in RA mice across tests. Mice that consumed more pomegranate treatment had a
reduction in the number of faults per distance in the foot fault test, r = -.71, p = .05
(Figure 53). More pomegranate treatment consumption in RA mice also led to better
average performance on the rotarod (stayed on the test longer), especially in the most
challenging speed of the test, r = .73, p = .04 (Figure 54). In addition, pomegranate
treated RA mice that spent more time in the perimeter of open field had better
performance on the rotarod, especially in the most challenging speed of the test, r = .74, p
= .04 (Figure 55).
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Figure 53. RA mice that consumed more pomegranate treatment made fewer faults in
the foot fault test, p = .05.

Figure 54. RA mice that consumed more pomegranate treatment had improved
performance on average in the most challenging rotarod trials, p = .05.
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Figure 55. Pomegranate treated RA mice that spent more time in the periphery in open
field testing had improved performance on average in the most challenging rotarod trials,
p < .05.
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CHAPTER FOUR
DISCUSSION

Effects of Repeated Concussion
Animal models have been developed to better understand the pathology and
consequences of trauma, particularly mild injuries. The purpose of this study was to
explore the effects of repeated brain insults on behavior, as well as the protective effects
of pomegranate juice on injury-induced deficits. We hypothesized rmCHI would induce
behavioral deficits and found that mice that received rmCHI did in fact evidence
significant fine motor deficits. Findings from this study are consistent with several
studies investigating mild brain injury.
Closed head injury (CHI) is a rodent model of TBI that is more representative of
human mTBI/concussive conditions than the more invasive CCI and FPI models. The
latter models require craniectomy, which may itself lead to cortical inflammation and
behavioral changes (Mouzon et al., 2012). In the CHI model, the pneumatic or
electromagnetic impact device drives a motorized to impact the skull directly. This model
produces a mild injury that prevents cortical contusions, skull fractures, prolonged apnea,
and also keeps mortality to a minimum (Mouzon et al., 2012). In addition, widespread
damage to white matter and subsequent connectivity disruption lead to cognitive and
neuropsychological impairments (Kim et al., 2014).
The diffuse nature of CHI leads to greater axonal injury over a large brain region,
including the motor cortex (Eucker et al., 2014). Alterations in cell function such as
excitotoxicity, calcium up-regulation, depolarization, and vulnerability of the blood brain
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barrier are components of the secondary response that continue to promote global brain
damage (Greve & Zink, 2009; Lakowski, Creed, & Raghupati, 2015). In a midline fluid
percussion injury model, diffuse injury leads to the sensitization of microglia and the
inflammatory system (Fenn et al., 2013). Our findings demonstrate that motor deficits
may have emerged in rmCHI mice because of the brain’s increased vulnerability to the
initial insult, wherein the subsequent mCHI further exacerbated the brain’s sensitivity to
injury and contributed to the observation of behavioral deficits.
In a recent study published by our lab, we used a mild closed head injury (mCHI)
model to characterize long-term behavioral deficits in young adult mice with a single
mCHI and repeated mild CHI (rmCHI). We found that this model (1 mm depression at 40
psi) produced consistent mild rotational injuries that led to the emergence of lateappearing (90 days post-injury) motor and affective deficits (Bajwa, et al., 2016). The
injury (2 mm depression at 4 m/s) in rmCHI mice for our study produced mild rotational
injuries that led to acute motor and cognitive deficits. These deficits are consistent to
several studies investigating repeated TBI.
We found motor deficits in the foot fault task and the beam balance test.
However, we did not find hyperactivity or altered rotarod performance as reported in
other studies on concussion. This may be due to the differences in our methodology. For
example, Kane et al. (2012) used a repeated mild weight-drop TBI mouse model to
induce brain injury. Their model may have produced a larger injury than our mild injury.
In a study by Mouzon and colleagues (2012), researchers reported impaired rotarod
performance after repeated concussions. Yet again, there were variations in the method
they followed as compared to ours. In their study, they induced 5 injuries in 48-hour
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intervals as opposed to our study where we induced 2 repeated concussions. In addition,
their study induced concussion along the midline, whereas we induced bilateral
concussions. The rotation of the brain, location of injury, and the pathophysiology in our
model may significantly differ and this may explain why they found significant changes
in rotarod performance where our study did not.
In our study, repeated CHI led to impaired performance in the water maze. These
results are consistent with previous research by Creeley et al. (2004) and Mouzon et al.
(2012). In the study by Creeley et al., they used an rmCHI model that included three
weight-drop sessions 24 hours apart led. Their results demonstrated impaired water maze
spatial learning performance in their subjects. (Creeley et al., 2004). Likewise, Mouzon et
al. reported significant spatial learning deficits, where they used a model of repeated
concussion where five injuries were given at 48-hour intervals.
We hypothesized that our injury model would result in significant differences in
affective symptoms between injured animals and control animals. This hypothesis was
based on several studies that demonstrated that brain lesions can contribute to affective
outcomes., Frontal lobe and right hemispheric injuries are particularly associated with
deviations from normal affective behavior (McDonald, Saykin, & McAllister, 2012). One
study that included a repeated mild lateral FPI model revealed that rats subjected to 5
mild concussions demonstrated increased anxiety and depression-like symptoms as
compared to comtrol rats. This injury model also produced short (24 hr) and long-term (8
weeks) cognitive impairments (Shultz et al., 2012). Another study that used a midline
fluid percussion injury model demonstrated that diffuse injury led to depressive-like
behavior at 7 dpi (Fenn et al., 2013). Depressive-like behavior was also manifested at 7
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dpi as a result of diffuse injury in another study that used a weight-drop injury model
(Milman et al., 2005). However, our model of rmCHI did not lead to increased affective
symptoms. This may be attributed to differences in the severity and the pathophysiology
of the injury. Repeated CHI mice had motor deficits, but the injury may have not been
severe enough to produce ongoing widespread changes that lead to short-term affective
symptoms, but may lead to the presentation of long-term depression-like symptoms as we
have previously reported (Bajwa et al., 2016).

Effects of Anesthesia
Our results showed that anesthesia (single exposure 25 minutes or 2 exposures
separated by 3 days) led to risk taking behaviors and impaired performance in learning
tasks. Anesthesia is generally considered a safe intervention and is routinely used in
many simple and complex surgical procedures performed in all age groups. Anesthesia
acts on the central nervous system by interacting with synaptic transmission and
inhibiting neuronal communication between several brain regions (Harrison 1993).
Anesthetics are easily controllable and have few long-lasting side effects in clinical and
experimental animal research. In research on the topic, it has been shown that single or
repeated exposure to general anesthesia resulted in no spatial learning performance
changes in young or aged mice when tested less than 24 hours after anesthesia
(Butterfield, Graf, Ries, & MacLeod, 2004). In fact, isoflurane has been found to be
neuroprotective and may reduce excitotoxicity in rodents (Burchell, Dixon, Tang, &
Zhang, 2013; Harada, Kelly, Cole, Drummond, & Patel, 1999; Sakai et al., 2007; Statler
et al, 2006).
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However, our results are not without precedence: some studies have also reported
detrimental effects of anesthesia. Some research findings suggest that despite such
widespread use, isoflurane administration can lead to various pathophysiological and
cognitive alterations (Jevtovic-Todorovic et al., 2003). Isoflurane reduces the activity of
action potentials by causing a reduction in conductance by altering the rate that gap
junctions open and close. Too much isoflurane can reduce neuronal signaling, eventually
leading to loss of communication and cell death. Some studies show that isoflurane alters
metabolic processes such as hypoglycemia (Loepke, McCann, Kurth, & McAuliffe,
2006), cerebral blood flow (Reinstrup et al., 1995; Schlunzen, Cold, Rasmussen, &
Vafaee, 2006; Li, Patel, Wang, & Zhang, 2014), induces neurotoxicity leading to both
neuronal apoptosis (Kawaguchi et al., 2004; Sinner, Becke, & Engelhard, 2014) and glial
apoptosis (Brambrink et al, 2012; Creeley et al., 2014). These physiological changes have
been found to impair short-term memory (Ramage et al., 2013), long-term memory, and
increase learning deficits (Rothstein, Simkins, & Nunez, 2008; Lee, Chan, Hazarika,
Vutskits, & Sall, 2014). Studies have also reported acute spatial learning deficits (< 8
days) in adult rats exposed to a single anesthesia treatment. (Cao et al., 2015; Carr,
Torjman, Manu, Dy, & Goldberg, 2011). Another study reported that adult rats tested 4
weeks after 4 hours of isoflurane exposure had poor long-term retention of the platform’s
location in the water maze, whereas single isoflurane exposure did not affect performance
(Callaway, Jones, & Royse, 2012). These findings suggest that behavioral impairments
are present several weeks after significant exposure of isoflurane. Our findings suggest
that isoflurane may have caused increased cellular apoptosis and associated degeneration
that led cognitive deficits (risk-taking behaviors). Thus, an anesthesia control may not be
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a suitable control for brain-injured animals. Future studies should also incorporate naïve
animals (without anesthesia) as a control.

Effects of Pomegranate Juice
Mice received pomegranate juice in their drinking water and pomegranate juice is
known to be high in antioxidant and anti-inflammatory properties. We hypothesized that
pomegranate juice supplementation would lessen or even ameliorate the degree of
behavioral deficits induced by rmCHI. Our findings reveal that pomegranate juice led to
fewer motor deficits in rmCHI mice, but not repeated anesthesia mice.
Some studies have reported improved cortical integrity and behavioral outcomes
with pomegranate treatment. Alzheimer’s-like transgenic mice that consumed a
pomegranate-enriched water for 6 months found the submerged platform faster in the
water maze (spatial learning tasks) than mice that consumed the control water (Hartman
et al., 2006). In another study from our lab, pomegranate juice treatment for 10 weeks
ameliorated irradiation induced depression-like behavior and improved motor
performance in the rotarod in male mice (Dulcich & Hartman, 2013).
Another study by Loren, et al. showed that maternal supplementation with
pomegranate juice influenced mice pup outcome after brain injury (2005). These pups
had less cortical tissue loss resulting from neonatal stroke when exposed in utero to
pomegranate juice, regardless of dose. Interestingly, these mice were on the treatment for
a total of 15 days and found significant improvements, whereas in our study, we found
only subtle motor improvements from pomegranate juice administration. These
differences may be attributed to the fact that mice were exposed to juice in utero during
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critical development periods that may have primed cells against inflammation and injury.
Another reason why we may not have been able to reproduce the beneficial
results of other research and those produced by our lab might be because of the duration
of treatment in our study. Perhaps, longer treatment duration for adult mice are necessary
to see significant improvement in behavior, compared to a shorter duration in young
mice.
We also reported that pomegranate treatment worsened performance in the water
maze (spatial 1) in rmCHI mice. It is likely that these findings may have been a
spontaneous effect. There is also research that suggests the flavonoids found in
pomegranate juice are metabolized extensively in the body and, as a result, lower levels
of flavonoids may pass through the blood brain barrier to reduce oxidative species
(Spencer et al., 2009). The levels of flavonoids that pass through the blood brain barrier
may be attributed to individual differences in animals, regardless of the amount
consumed.
Additionally, the effectiveness of the pomegranate treatment in our injury model
may have been influenced by a hormetic response. Hormesis has been widely researched
in the toxicology field; it is defined as “a process in which exposure to a low dose of a
chemical agent or environmental factor that is damaging at higher doses induced an
adaptive beneficial effect on the cell or organism” (Mattson, 2008). Hormesis is an
integral part to the normal physiological function of cells and organisms. The response of
a cell or organism to the low dose of the toxin is considered an adaptive compensatory
process following an initial disruption in homeostasis (Mattson, 2008). As the disruption
occurs, a hormetic stress response is triggered, activating cellular defense mechanisms
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that increase antioxidant pathways and proteins associated with cellular survival (i.e.
Nrf2 and NFB) (Luna-Lopez, Gonzalez-Puertos, Lopez-Diazguerrero, & Konigsberg,
2014). Preconditioning ischemia is one of the most common experimental models of
hormesis. This occurs when the heart or brain are subjected to a brief period of mild
ischemia. During this injury phase, cells become resistant to cellular apoptosis induced by
a larger event (i.e. stroke) (Pong, 2004;Yellon & Downey, 2003). Interestingly, ischemia
exhibits a dose dependent response, in that brief periods of mild ischemia may be
neuroprotective and longer periods result in cellular damage (Mattson, 2008).
As it relates to our research, the first impact in rmCHI may have triggered a
neuroprotective response. The second impact was given in a short time frame relative to
first impact while the brain had not fully recovered and remained in an inflammatory
state. We believe the second impact (3 days later) exacerbated the oxidative and
inflammatory response (increased microglia), such that it eliminated the antioxidant
and/or anti-inflammatory pathways that were ongoing as a result of pomegranate
treatment.
The inflammatory response is triggered as a result of injury or the invasion of
pathogens. Inflammation in the central nervous system is characterized by increased
blood brain barrier permeability, macrophage activation, glial activation, and the release
of cytokines. During injury, microglia are recruited to the site and undergo a series of
morphologic and phenotypic changes that attempt to re-establish homeostasis. The
increased microglial response may have caused an increase in the release of proinflammatory cytokines and proteases. This study has yet to determine whether
pomegranate juice influenced the microglia after rmCHI. These results may provide some
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insight on whether pomegranate juice attenuated inflammation in animals and perhaps
these effects have yet to be translated to altered cellular changes (behavior). Several
studies have reported several ways pomegranates and its derivatives affect inflammatory
cascade in the brain. Pomegranate extract has been shown to treat inflammation and
attenuate the release of TNF (pro-inflammatory cytokine) from microglial cells (Jung et
al., 2006) and ellagic acid has been shown to reduce oxidative stress, reactive nitrogen
species (Priyadarsini et al., 2002), and the release of IL-6 and IL-1 inflammatory
cytokines (Farbood et al., 2015).

Future Directions
Determining the specific mechanisms and activation of anti-inflammatory
pathways by pomegranate juice in the brain and behavior is beyond the scope of the
study. Future projects should determine the levels of oxidative stress, apoptosis, and
neurogenesis. In addition, a dose dependent that assess different dilutions of pomegranate
juice in our model of repeated concussions should be conducted. These directions may
provide critical insight to how pomegranate juice may influence mild brain injuries.
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